6. Literaturverzeichnis

Abrams B, Pickett KE (1999): Maternal nutrition, Creasy RK, Resnik R, Ed, Maternal-fetal medicine (vol. 4), pp. 122-131, W.P. Saunders company, Philadelphia, Pennsylvania.

Acbay O, Gundogdu S (1996): Can metformin reduce insulin resistance in polycystic ovary syndrome?, Fertil Steril, (vol. 65), pp.946-949.

Adams J, Polson DW, Franks S (1986): Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism, Br J Med Clin Res Ed, (vol. 293), pp.355-359.

Adams PW, Wynn V, Folkard J, Seed M (1976): Influence of oral contraceptives, puridoxine (vitamin B6), and tryptophan on carbohydrate metabolism, Lancet, (vol. 1), pp.759-764.

Adashi EY, Resnick CE, D´Ecrole AJ, Svoboda ME, Van Wyk JJ (1985): Insulin-like growth factors and intraovarian regulators of granulosa cell growth and function, Endocr Rev, (vol. 6), pp.400-420.

Adeghate E (2000): Effects of oral contraceptive steroid hormones on metabolic parameters of streptozotocin-induced diabetic rat, Contraception, (vol. 62), pp.327-329.

Ader M, Bergmann RN (1994): Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose, Am J Physiol, (vol. 266), pp.17-25.

Aerts, L.; Holemans, K. and Van Assche, F. A. (1990): Maternal diabetes during pregnancy: consequences for the offspring, Diabetes Metab Rev, (vol. 6), pp.147-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2091909

Ahima RS, Dushay J, Flier SM, Prabakaran D, Flier JS (1997): Leptin accelerates the onset of puberty in normal female mice, J Clin Invest, (vol. 999), pp.391-395.

Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, Nemesh J, Lane CD, Schaffner SF, Bolk A, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Dale M, Groop L, Lander ES (2000): The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nat Genet, (vol. 26), pp.76-80.

Amatayakul K, Suriyanon V (1985): The effects of long-acting injectable contraceptives on carbohydrate metabolism, Int J Gynaecol Obstet, (vol. 23), pp.361-368.

Amato G, Izzo A, Tucker AT, Bellastella A (1999): Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization, Fertil Steril, (vol. 72), pp.454-457.

American College of Physicians (1992): Guidelines for counseling postmenopausal women about preventive hormone therapy, Ann Intern Med, (vol. 117), pp.1083-1041.

American Diabetes Association (1998): Consensus Development Conference on Insulin Resistance: 5-6 November 1997, Diabetes Care, (vol. 21), pp.310-314.

American Diabetes Association (2000): Consensus conference on type 2 diabetes in children, Diabetes Care, (vol. 23), pp.381-389.

American Diabetes Association (2000): Type 2 diabetes in children and adolescents, Pediatrics, (vol. 105), pp.671-680.

American Diabetes Association (2002): Preconseption care of women with diabetes, Diabetes Care, (vol. 25), No. Suppl 1, pp.S82-S89.

American Diabetes Association (2003): Gestational diabetes mellitus, Diabetes Care, (vol. 26), No. Suppl 1, pp.S103-S105.

American Diabetes Assoziation, National Institute of Diabetes, Digestive and Kidney Diseases (2003): The prevention or delay of type 2 diabetes, Diabetes Care, (vol. 26), No. Suppl 1, pp.62-69.

American Fertility Society (1985): Revised American Fertility Society classification of endometriosis, Fertil Steril, (vol. 43), pp.351-352.

Amiel S, Caprio S, Sherwin R, Plewe G, Haymond M, Tamborlane W (1991): Insulin resistance of puberty: a defect to peripheral glucose metabolism, J Clin Endocrinol Metab, (vol. 72), pp.277-282.

Amiel S, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane W (1986): Impaired insulin action in puberty. A contributing faction to poor glycemic control in adolescents with diabetes, N Engl J Med, (vol. 315), pp.215-219.

Andersen, R. E.; Crespo, C. J.; Bartlett, S. J.; Cheskin, L. J. and Pratt, M. (1998): Relationship of physical activity and television watching with body weight and level of fatness among children: results from the Third National Health and Nutrition Examination Survey, Jama, (vol. 279), pp.938-942. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9544768

Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Björntorp P (1997): Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab, (vol. 82), pp.638-648.

Andersson DKG, Svaardsudd K (1995): Longterm glycemic control relates to mortality in type II diabetes., Diabetes Care, (vol. 18), pp.1534-1543.

Anttila L, Karjala K, Penttilä T-A, Ruutiainen K, Ekblad U (1998): Polycystic ovaries in women with gestational diabetes, Obstet Gynecol, (vol. 92), pp.13-16.

Araujo DA, Farias ML, Andrade AT (2002): Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus, Climacteric, (vol. 5), pp.286-292.

Arslanian S, Suprasongsin C (1996): Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?, J Clin Endocrinol Metab, (vol. 81), pp.1058-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8772576

Arslanian SA (2000): Type 2 diabetes mellitus in children: pathophysiology and risk factors, J Pediatr Endocrinol Metab, (vol. 13), No. Suppl 6, pp.1385-1394.

Arslanian SA, Kalhan SC (1994): Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty, Diabetes, (vol. 43), pp.908-914.

Arslanian SA, Suprasongsin C, Janosky JE (1997): Insulin secretion and sensitivity in black versus white prepubertal healthy children, J Clin Endocrinol Metab, (vol. 82), pp.1923-1927.

Asunción M, Calvo RM, San Millan JL, Sancho J, Avila S, Scobar-Morreale HF (2000): A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women form Spain, J Clin Endocrinol Metab, (vol. 85), pp.2434-2438.

Avvad CK, Holeuwerger R, Silva VC, Bordallo MA, Breitenbach MM (2001): Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence, Gynecol Endocrinol, (vol. 15), pp.170-177.

Bagatell CJ, Bremner WJ (1996): Androgens in men - uses and abuses, N Engl J Med, (vol. 334), pp.707-714.

Bailey CJ, Turner RC (1996): Metformin, N Engl J Med, (vol. 334), pp.574-579.

Baird DT (1993): Ovulation induction: current status and future prospects of gonadotropin therapy, Adashi EY, Leung PCK, Ed, The Ovary, pp. 529-544, Raven Press, New York.

Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JP, et al (1996): Leptin is a metabolic signal to the reproductive system, Endocrinology, (vol. 137), pp.3144-3147.

Barbieri RL, Makris A, Ryan KJ, (1983): Effects of insulin on steroidogenesis in cultured porcine ovarian theca., Fertil Steril, (vol. 40), pp.237-241.

Barbieri RL, Markis A, Randall RW, et al (1986): Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J Clin Endocrinol Metab, (vol. 62), pp.904-910.

Barbieri RL, Markis A, Ryan KJ (1984): Insulin stimulates androgen accumulation in incubations of ovarian stroma and theca, Obstet Gynecol, (vol. 64), No. Suppl 3, pp.S74-S80.

Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K , Clark PM (1993): Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrom X): relation to reduced fetal growth, Diabetologia, (vol. 36), pp.62-67.

Baron AD, Brechtel G, Wallace P, Edelmann SV, (1988): Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans, Am J Physiol, (vol. 255), pp.E769-E774.

Barrett-Conner E (1991): Postmenopausal estrogen and prevention bias, Ann Intern Med, (vol. 115), pp.455-456.

Barrett-Conner E, Laasko M (1990): Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels, Arteriosclerosis, (vol. 10), pp.531-534.

Barrett-Conner E, Wingard DL, Criqui MH (1989): Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited, JAMA, (vol. 261), pp.2095-2100.

Bates GW, Whitworth NS (1982): Effect of body weight reduction on plasma androgens in obese, infertile women, Fertil Steril, (vol. 38), pp.406-409.

Battaglia C, Regnani G, Mancini F, Iughetti L , Flamigni C, Venturoli S (2002): Polycystic ovary syndrome in childhood: a common finding in daughters of PCOS patients. A pilot study, Hum Reprod, (vol. 17), pp.771-776.

Battaglia FC, Meschia G (1978): Principal substrates of fetal metabolism, Physiol Rev, (vol. 58), pp.499-527.

Beck P (1977): Effect of progestins on glucose and lipid metabolism, Ann N Y Acad Sci, (vol. 286), pp.434-445.

Belchetz PE (1994): Hormonal treatment of postmenopausal women, N Engl J Med, (vol. 330), pp.1062-1071.

Belgorosky A, Rivarola MA (1988): Progressive increase in non-sex hormone-binding globulin-bound testosterone and estradiol from infancy to late puberty in girls, J Clin Endocrinol Metab, (vol. 67), pp.234-237.

Benassi L, Tridenti G, Orlandi N, Pezzarossa A (1991): Glucose tolerance and insulin release in adolescent female, J Endocrinol Invest, (vol. 14), pp.751-756.

Berenson GS, Srinivasan SR, Wattigney WA, Harsha DW, (1993): Obesity and caridovascular risk in children., Ann N Y Acad Sci, (vol. 699), pp.93-103.

Berga SL, Mortola JF, Girton L, et al (1989): Neuroendocrine aberrations in women with functional hypothalamic amenorrhea, J Clin Endocrinol Metab, (vol. 68), pp.301-308.

Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjo T, (1993): Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin., Fertil Steril, (vol. 59), pp.323-331.

Bergmann RN (1989): Toward the understanding of glucose tolerance: minimal modal approach, Diabetes, (vol. 38), pp.1512-1527.

Bergmann RN, Watanabe R, Rebrin K, et al (1996): Toward an integrated phenotype in pre-NIDDM, Diabet Med, (vol. 13), pp.S67-S77.

Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA (1996): Effect of troglitazone on insulin sensitivity and pancreatic b-cell function in women at high risk for NIDDM, Diabetes, (vol. 45), pp.1572-1579.

Bertoli A, DePirro R, Fusco A, Greco A, Magnatta R, Lauro R (1980): Differences in insulin receptors between men and menstruating women and the influence of sec hormones on insulin binding in the menstrual cycle, J Clin Endocrinol Metab, (vol. 50), pp.246-250.

Bikas D, Ahner R, Husslein P (1999): Physiologie des mütterlichen Organismus, Schneider H, Husslein P, Schneider KTM, Ed, Geburtshilfe, Springer Verlag, Berlin Heidelberg New York.

Billiar RB, Richardson S, Schwartz R, Posner B, Little B (1987): Effects of chronically elevated androgen and estrogen on the glucose tolerance test and insulin response in female rhesus monkeys, Am J Obstet Gynecol, (vol. 157), pp.1297-1302.

Billig H, Chun SY, Eisenhauer K and Hsueh AJ, (1996): Gonadal cell apoptosis: hormone-regulated cell demise, Human Reproduction Update, (vol. 2), pp.103-117.

Biswas A, Viegas OA, Coeling Bennink HJ, Korver T, Ratnam SS (2001): Implanon(R) contraceptive implants: effects on carbohydrate metabolism, Contraception, (vol. 63), pp.137-141. http://www.sciencedirect.com/science/article/B6T5P-430G367-4/2/ae2d6ac5872932ce24bde09ab6d973cc

Björntorp P (1993): Viszeral obesity: a "civilization syndrome", Obes Res, (vol. 1), pp.206-222.

Bloch CA, Clemons P, Sperling MA (1987): Puberty decreases insulin sensitivity, J Pediatr, (vol. 110), pp.481-487.

Bloomgarden ZT (2003): American Association of Clinical Endocrinologists (AACE) Consensus Conference on the insulin resistance syndrome. 25-26 August 2002, Washington, DC, Diabetes Care, (vol. 26), pp.1297-1303.

Board JA (1971): Continuous 0.35mg as an oral contraceptive agent, Am J Obstet Gynecol, (vol. 109), pp.531-535.

Boden G (1997): Role of fatty acids in the pathogenesis of insulin resistance and NIDDM, Diabetes, (vol. 46), pp.3-10.

Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G, (1985): Relationship between degree of obesity and in vivo insulin action in man, Am J Physiol, (vol. 248), pp.E286-E291.

Boldori L, Marelli A (2000): Monitoring the trend of overweight children in Cremona (anni 1990-1998), Minerva Pediatr, (vol. 51), pp.21-27.

Bonara E, Zavaroni I, Alpi O, Pezzarossa A, Dall´Aglio E, Coscelli C, Butturini U (1987): Influence of the menstrual cycle on glucose tolerance and insulin secretion, Am J Obstet Gynecol, (vol. 157), pp.140-141.

Bongain A, Isnard V, Gillet J-Y (1998): Obesity in obstetrics and gynaecology, Eur J Obstet Gynecol Reprod Biol, (vol. 77), pp.217-228.

Bratusch-Marrain PR, Smith D, DeFronzo RA (1982): The effect of growth hormone on glucose metabolism and insulin secretion in man, J Clin Endocrinol Metab, (vol. 55), pp.973-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6749883

Brazilai N, Wang J, Massilon D, Vuguin P, Hawkin M, Rossetti L (1997): Leptin selective decrease visceral adiposity and enhances insulin action, J Clin Invest, (vol. 100), pp.3105-3110.

Breckwoldt M (1994): Geschlechtsspezifische Funktionen und ihre Störungen, Martius G, Breckwoldt M, Pfleiderer A, Ed, Lehrbuch der Gynäkologie und Geburtshilfe, pp. 333-371, Georg Thieme Verlag, Stuttgart-New York.

Breckwoldt M (1994): Störungen der Fruchtbarkeit, Martius G, Breckwoldt M, Pfleiderer A, Ed, Lehrbuch der Gynäkologie und Geburtshilfe, pp. 373-387, Georg Thieme Verlag, Stuttgart-New York.

Brewis AA (1993): Age and infertility in a Micronesian Atoll population, Hum Biol, (vol. 65), pp.593-609.

Brinton LA, Schairer C (1997): Editorial: Postmenopausal hormone-replacement therapy- time for a reappraisal?, N Engl J Med, (vol. 336), pp.1821-1822.

Broglio F, Arvat E, Benso A, Gottero C, Mucciolo G, Papotti M, Lely AJ, Deghenghi R, Ghigo E (2001): Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans, J Clin Endocrinol Metab, (vol. 86), pp.5083-5086.

Bronson FH (1986): Food-restricted, prepubertal, female rats: rapid recovery of luteinizing hormone pulsing with excess of food and full recovery of pubertal development with gonadotropin-releasing hormone, Endocrinology, (vol. 118), pp.2483-2487.

Brooks-Gunn, J. (1988): Antecedents and consequences of variations in girls' maturational timing, J Adolesc Health Care, (vol. 9), pp.365-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3049482

Brunzell JD, Robertson RP, Lerner RL, et al (1976): Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests, J Clin Endocrinol Metab, (vol. 42), pp.222-229.

Brussaard HE, Leuven JA, Frölich M, Kluft C, Krans HM (1997): Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM, Diabetologia, (vol. 40), pp.843-849.

Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magoffin DA (1996): Serum immunoreactive leptin concentrations in polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 81), pp.4166-4169.

Buchanan TA, Kjos SL (1999): Commentary. Gestational diabetes: risk of myth?, J Clin Endocrinol Metab, (vol. 84), pp.1854-1857.

Buchanan TA, Metzger BE, Frienkel N, Bergman RN (1990): Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes, Am J Obstet Gynecol, (vol. 162), pp.1008-1014. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2183610

Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK (1999): Antepartum predictors of the develpment of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes, Diabetes, (vol. 48), pp.2430-2436.

Buchler D, Warren JC (1966): Effects of estrogen on glucose tolerance, Am J Obstet Gynecol, (vol. 95), pp.479-483.

Burchfiel CM, Hamman RF, Marshal JA, Baxter J, Kahn LB, Amirani JJ (1990): Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study, Am J Epidemiol, (vol. 131), pp.57-70.

Burghen GA, Givens JR, Kitabchi AE (1980): Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease, J Clin Endocrinol Metab, (vol. 50), pp.113-116.

Butkiewicz Ek, Leibson C, O´Brien PC, Palumbo PJ, Rizza RA, (1995): Insulin therapy for diabetic ketoacidosis, Diabetes Care, (vol. 18), pp.1187-1190.

Butte NF (2000): Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus, Am J Clin Nutr, (vol. 71), No. Suppl, pp.1256S-1261S.

Butte NF, Hopkinson J, Nicholson M (1997): Leptin in human reproduction: serum leptin levels in pregnant and lactating women, J Clin Endocrinol Metab, (vol. 82), pp.585-589.

Byrne MM, Sturis J, Cavaghan M, O´Meara NM, Polonsky KS (2000): Insulin secretion in humans. Physiological regulation and alterations in disease states, LeRoith D, Taylor SI, Olefsky JM,, Ed, Diabetes mellitus: a fundamental and clinical text, Philadelphia.

Cagnacci A, Soldani R, Carriero P, Paoletti A, Fioretti P, Melis G (1992): Effects of low doses of transdermal 17 b-estradiol on carbohydrate metabolism in postmenopausal women, J Clin Endocrinol Metab, (vol. 74), pp.1396-1400.

Cagnacci A, Tuveri F, Cirillo R, Setteneri AM, Melis GB, Volpe A (1997): The effect of transdermal 17-b-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration, Maturitas, (vol. 28), pp.163-167.

Calles-Escandon J, Robbins DC (1987): Loss of early ohase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose, Diabetes, (vol. 36), pp.1167-1172.

Caprio S (1999): Insulin: the other anabolic hormone of puberty, Acta Paediatr Scand Suppl, (vol. 88), pp.84-87.

Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV (1996): Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children, Diabetologia, (vol. 39), pp.1489-97. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8960831

Caprio S, Cline G, Boulware S, Permanente C, Sherwin RS, Shulmann G, et al (1994): Effects of puberty and diabetes on the metabolism of insulin-sensitive fuels, Am J Physiol, (vol. 266), pp.E885-E891.

Caprio S, Plewe G, Diamond MP, Boulware S, Sherwin RS, Tamborlane W (1989): Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity, J Pediatr, (vol. 114), pp.963-967.

Caprio, S.; Hyman, L. D.; Limb, C.; McCarthy, S.; Lange, R.; Sherwin, R. S.; Shulman, G. and Tamborlane, W. V. (1995): Central adiposity and its metabolic correlates in obese adolescent girls, Am J Physiol, (vol. 269), pp.E118-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7631766

Carey A, Chan F, Short F, White D, Williamson R, Franks S (1993): Evidence for a single gene causing polycystic ovaries and male pattern baldness, Clin Endocrinol (Oxf), (vol. 38), pp.653-658.

Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E (2003): The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance: Importance of insulin secretion and resistance, Diabetes Care, (vol. 26), pp.1333-1337. http://care.diabetesjournals.org/cgi/content/abstract/26/5/1333

Caro JF (1991): Insulin resistance in obese and nonobese man, J Clin Endocrinol Metab, (vol. 73), pp.691-695.

Caro JF, Dohm LG, Pories WJ, Sinha MK (1989): Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and Type II diabetes, Diabetes Metab Rev, (vol. 5), pp.665-689.

Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996): Leptin: The tale of an obesity gene, Diabetes, (vol. 45), pp.1455-1462.

Catalano PM (1994): Carbohydrate metabolism and gestational diabetes, Clin Obstet Gynecol, (vol. 37), pp.25-38.

Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Sims EAH (1986): Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes, Am J Obstet Gynecol, (vol. 155), pp.1255-1263.

Catalano PM, Huston L, Amini SB, Kalhan SC (1999): Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes, Am J Obstet Gynecol, (vol. 180), pp.903-916.

Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J (2003): Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus, J Nutr, (vol. 133), pp.1674S-1683S.

Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, Sims EA (1993): Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes, Am J Physiol, (vol. 264), pp.E60-E67.

Catalano PM, Vargo KM, Bernstein IM, Amini SB (1991): Incidence and risk factors associated with abnormal glucose tolerance in women with gestational diabetes, Am J Obstet Gynecol, (vol. 165), pp.914-919.

Caubo B, De Vinna RS, Tonetta SA, (1989): Regulation of steroidogenesis in cultured porcine theca cells by growth factors., Endocrinology, (vol. 125), pp.321-326.

Cavaghan MK, Ehrmann DA, Polonsky KS (2000): Interactions between insulin resistance and insulin secretion in the development of glucose intolerance, J Clin Invest, (vol. 106), pp.329-333.

Cawood EH, Bancroft J, Steel JM (1993): Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control, Diabetic Med, (vol. 10), pp.444-448.

Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994): Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men, Diabetes Care, (vol. 17), pp.961-969.

Chang RJ, Katz SE (1999): Diagnosis of polycystic ovary syndrome, Endocrinol Metab Clin North Am, (vol. 28), pp.397-408.

Chang RJ, Nakamura RM, Judd HL, Kaplan SA (1983): Insulin resistance in nonobese patients with polycystic ovarian disease, J Clin Endocrinol Metab, (vol. 57), pp.356-359.

Chapman IM, Wittert GA, Norman RJ (1997): Circulating leptin concentrations in polycystic ovary syndrome - relation to anthropometric and metabolic parameters, Clin Endocrinol (Oxf), (vol. 46), pp.175-181.

Chasen-Taber L, Willett WC, Stampfer MJ, Hunter DJ, Colditz GA, Spiegelmann D, Manson JE (1997): A prospective study of oral contraceptives and NIDDM among US women, Diabetes Care, (vol. 20), pp.330-335.

Chehab FF, Mounzih K, Lu R, Lim ME (1997): Early onset of reproductive function normal female mice treated with leptin, Science, (vol. 275), pp.88-90.

Chen KW, et al (1995): Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM, Diabetes Care, (vol. 18), pp.747-753.

Chen M, Bergmann RN, Pacini G, Porte D (1985): Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased ß-cell function, J Clin Endocrinol Metab, (vol. 60), pp.13-20.

Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM (1999): Risk factors for heart failure in the eldery: a prospective community-based study, Am J Med, (vol. 106), pp.605-612.

Cherrington AD, Sindelar D, Edgerton D, Steiner K, McGuinness OP (2002): Physiological Consequences of Phasic Insulin Release in the Normal Animal, Diabetes, (vol. 51), pp.S103-108. http://diabetes.diabetesjournals.org/cgi/content/abstract/51/suppl_1/S103

Cheung CC, Thorton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA (1997): Leptin is a metabolic gate for the onset of puberty in the female rat, Endocrinology, (vol. 138), pp.855-858.

Chinn S, Rona RJ (2001): Prevalence and trends in overweight and obesity in three cross-sectional studies of British children, 1974-94, BMJ, (vol. 322), pp.24-26.

Chisolm GM , Irwin KC, Penn MS (1992): Lipoprotein oxidation and lipoprotein induced cell injury in diabetes, Diabetes, (vol. 41), No. Suppl 2, pp.61-66.

Chun SY, Billig H, Tilly JL, Furuta U, Tsafriri A, Hsueh AJ, (1994): Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor-I., Endocrinology, (vol. 135), pp.1845-1853.

Ciraldi TP, El-Roeiy A, Madar Z, et al (1992): Cellular mechanisms of insulin resistance in polycystic ovarian syndrome, J Clin Endocrinol Metab, (vol. 75), pp.577-583.

Ciraldi TP, Morales AJ, Hickman MG, et al (1997): Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity, J Clin Endocrinol Metab, (vol. 82), pp.1421-1425.

Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ (1995): Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women, Hum Reprod, (vol. 10), pp.2705-2712.

Clark CM (1998): How should we respond to the worldwide diabetes epidemic?, Diabetes Care, (vol. 21), pp.475-476.

Clark PA, Rogol AD (1996): Growth hormones and sex steroid interactions at puberty, Endocrinol Metab Clin North Am, (vol. 25), pp.665-681.

Clausen JO, Borch-Johnsen K, Ibsen H, Bergmann RN, Hougaard P, Winther K, Pedersen O (1996): Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness and life-style factors., J Clin Invest, (vol. 98), pp.1195-1209.

Clayton RN, Odgon V, Hodgkinson J , Worswick L, Rodin DA, Dyer S, Meade TW (1992): How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?, Clin Endocrinol (Oxf), (vol. 37), pp.127-134.

Cohen JC, Hickman R (1987): Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids, J Clin Endocrinol Metab, (vol. 64), pp.960-963.

Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995): Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med, (vol. 122), pp.481-486.

Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE (1990): Weight as a risk factor for clinical diabetes in women, Am J Epidemiol, (vol. 132), pp.501-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2389754

Cole TJ, Bellizi MC, Flegal KM, Dietz WH, (2000): Establishing a standard definition for child overweight and obesity worldwide: international survey., BMJ, (vol. 320), pp.1240-1243.

Collaborative Group on Hormonal Factors in Breast Cancer (1997): Breast cancer and hormone replacement therapy: collaborative reanalysis of data form 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer, Lancet, (vol. 350), pp.1047-1059.

Conover CA, Lee PDK, Kanaley JA, et al (1992): Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans, J Clin Endocrinol Metab, (vol. 74), pp.1355-.

Conway DL, Langer O (1998): Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean delivery, Am J Obstet Gynecol, (vol. 78), pp.922-925.

Conway G, Agrawal R, Betteridge DJ, Jacobs HS (1992): Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome, Clin Endocrinol (Oxf), (vol. 37), pp.19-25.

Conway GS, Jacobs HS (1997): Leptin - a hormone of reproduction, Hum Reprod, (vol. 12), pp.633-635.

Cooper GS, Ephross SA, Sandler DP (2000): Menstrual pattern and risk of adult-onset diabetes mellitus, J Clin Epidemiol, (vol. 53), pp.1170-1173.

Crave JC, Fimbel S, Lejeune H, et al (1995): Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women, J Clin Endocrinol Metab, (vol. 80), pp.2057-2062.

Crespo CJ, Smit E, Snelling A, Sempos CT, Andersen RE (2002): Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women. Results from the Third National Health and Nutrition Examination Survey (NHANES III), Diabetes Care, (vol. 25), pp.1675-1680.

Crook D, Godsland I (1998): Safety evaluation of modern oral contraceptives. Effects of lipoprotein and carbohydrate metabolism, Contraception, (vol. 57), pp.189-201.

Crowley WF (1996): New tools for pituary-gonadal assessment, Filicori M, Flagmini C, Ed, The Ovary: Regulation, Dysfunction and Treatment, pp. 287-293, Elsevier, Amsterdam.

Cruz ML, Bergmann RN, Goran MI (2002): Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with family history of type 2 diabetes, Diabetes Care, (vol. 25), pp.1631-1636.

Cudworth AG, Veevers A (1975): Carbohydrate metabolism in the menstrual cycle, Br J Obstet Gynecol, (vol. 82), pp.162-169.

Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001): A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans, Diabetes, (vol. 50), pp.1714-1719.

Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002): Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery, N Engl J Med, (vol. 346), pp.1623-1630.

Czech MP, Yu KT, Lewis RE, Davis RJ, Mottola C, McDonald RG, Necessary PC, Corvera S (1985): Insulin receptor kinase and its mode of signaling membrane components, Diabetes Metab Rev, (vol. 1), pp.33-58.

Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ (1998): Increasing prevalence of type 2 diabetes in American-Indian children, Diabetologia, (vol. 41), pp.904-910.

Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC (2000): Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity. A study of discordant sibships, Diabetes, (vol. 49), pp.2208-2211.

Dabelea D, Pettitt DJ, Jones KL, Arslanian SA (1999): Type 2 diabetes mellitus in minority children and adolescents. An emerging problem., Endocrinol Metab Clin North Am, (vol. 28), pp.709-729.

Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, et al (1992): Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long term follow-up focusing on natural history and circulating hormones, Fertil Steril, (vol. 7), pp.505-513.

Dale PO, Tanbor T, Vaaler S, Abyholm T (1992): Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovary syndrome: evidence of two distinct populations, Fertil Steril, (vol. 58), pp.487-491.

Damm P (1998): Gestational diabetes mellitus and subsequent development of overt diabetes mellitus, Dan Med Bull, (vol. 45), pp.495-509.

Damm P, Kuhl C, Bertelsen A, Molsted- Pedersen L (1992): Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus, Am J Obstet Gynecol, (vol. 167), pp.607-616.

Danadian K, Balasekaran G, Lewy V, Meza MP, Robertson R, Arslanian SA (1999): Insulin sensitivity in African-American children with and without family history of type 2 diabetes, Diabetes Care, (vol. 22), pp.1325-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10480778

Darko DA, Dornhorst A, Kennedy G, Mandeno RC, Seed M (2001): Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy, Diabetes Research and Clinical Practice, (vol. 54), pp.157-164.

Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S (2002): Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion, Diabetes, (vol. 51), pp.124-129.

Davidson MB (1987): Effect of growth hormone on carbohydrate and lipid metabolism, Endocr Rev, (vol. 8), pp.115-131.

Davis PH, Barnett AH (1998): Hormone replacement therapy women with diabetes mellitus: a survey of knowledge of risks and benefits, Practical Diabetes Int, (vol. 15), pp.78-80.

Davoren JB, Kasson BG, Li CH, Hsueh AJ, (1986): Specific insulin-like growth factor (IGF) I-binding sites on rat granulosa cells: relation to IGF action, Endocrinology, (vol. 119), pp.2155-2162.

De Cleyn K, Buytaert P, Coppens M (1989): Carbohydrate metabolism during hormonal substitution therapy, Maturitas, (vol. 11), pp.235-242.

De Clue TJ, Shah SC, Marchese M, Malone JI (1991): Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female, J Clin Endocrinol Metab, (vol. 72), pp.1308-1311.

De Pirro R, Forte F, Bertoli A, Greco A, Lauro R (1981): Changes in insulin receptors during oral contraception, J Clin Endocrinol Metab, (vol. 52), pp.29-33.

De Pirro R, Fusco A, Bertoli A, Greco AV, Lauro R (1978): Insulin receptors during the menstrual cycle in normal woman, J Clin Endocrinol Metab, (vol. 47), pp.1387-1389.

De Waard F (1991): Endocrine aspects of cancer, an epidemiological approach, J Steroid Biochem Mol Biol, (vol. 40), pp.15-19.

DeFronzo RA (1979): Glucose intolerance of aging. Evidence for tissue insensitivity to insulin, Diabetes, (vol. 28), pp.1095-1101.

DeFronzo RA (1981): Glucose intolerance with aging, Diabetes Care, (vol. 4), pp.493-501.

DeFronzo RA (1988): Lilly Lecture 1987. The triumvirate: B-cell, muscle, liver. A collusion responsible for type 2 diabetes, Diabetes, (vol. 37), pp.667-687.

DeFronzo RA (1997): Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis., Neth J Med, (vol. 50), pp.191-197.

DeFronzo RA, Bonadonna RC, Ferrannini E (1992): Pathogenesis of NIDDM: a balanced overview, Diabetes Care, (vol. 15), pp.318-368.

DeLeon FD, Vijayakumar R, Brown M, Rao CV, Yussman MA, Schultz GS (1986): Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis, Obstet Gynecol, (vol. 68), pp.189-194.

Després JP (1993): Abdominal obesity as important component of insulin-resistance syndrome, Nutrition, (vol. 9), pp.452-459.

Després JP (1993): Dyslipidemia and obesity., Baillieres Clin Endocrinol Metab, (vol. 92), pp.141-146.

Després JP, Lamarche B, Mauriege P, et al (1996): Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, (vol. 334), pp.952-957.

Di Blasio AM, Vigano P, Ferrari A, (1994): Insulin-like growth factor-II stimulates human granulosa-luteal cell proliferation in vitro., Fertil Steril, (vol. 61), pp.483-487.

Di Paola G, Puchulu F, Robini M, Nicholson R, Marti M (1968): Oral contraceptives and carbohydrate metabolism, Am J Obstet Gynecol, (vol. 101), pp.206-216.

Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al (1999): A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile, J Clin Endocrinol Metab, (vol. 84), pp.4006-4011.

Diamanti-Kandarakis E, Kouli CR, Tsianateli T, Bergiele AT, (1998): Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome, Eur J Endocrinol, (vol. 138), pp.269-274.

Diamanti-Kandarakis E, Mitrakou A, Hennes MMI, Platanissiotis D, Kaklas N, Spina J, Georgiadou E, Hoffmann RG, Kissebah AH, Raptis S (1995): Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome, Metabolism, (vol. 44), pp.525-531.

Diamond MP, Jacob R, Connolly-Diamond M, DeFronzo RA (1993): Glucose metabolism during the menstrual cycle. Assessment with the euglycemic hyperinsulinemic clamp, J Reprod Med, (vol. 38), pp.417-421.

Diamond MP, Simonson DC, DeFronzo RA (1989): Menstrual cyclicity has a profound effect on glucose homeostasis, Fertil Steril, (vol. 52), pp.204-208.

Diamond MP, Wentz AC, Cherrington AD (1988): Alterations in carbohydrate metabolism as they apply to reproductive endocrinology, Fertil Steril, (vol. 50), pp.387-397.

Dietz WH (1998): Health consequences of obesity in youth: childhood predictors af adult disease, Pediatrics, (vol. 101), pp.518-525.

Dietz WH, Bellizzi MC (1999): Introduction: the use of body mass index to assess obesity in children, Am J Clin Nutr, (vol. 70), pp.S123-125. http://www.ajcn.org/cgi/content/abstract/70/1/123S

Dinneen SF (1997): The post-prandial state: mechanisms of glucose intolerance, Diabet Med, (vol. 14), No. Suppl 3, pp.S19-S24.

Doar JWH, Wynn V (1970): Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels., Br J Med, (vol. 1), pp.149-152.

Doi T, Vlassara H, Kirstein M, et al, (1992): Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor, Proc Natl Acad Sci USA, (vol. 89), pp.2873-2877.

Dollmann J, Olds T, Norton K, Stuart D, (1999): The evolution of fitness and fatness in 10-11 year old Australien children: changes in distributional characteristics between 1985 and 1997., Pediatr Exer Sci, (vol. 11), pp.108-121.

Dorflinger LJ (2002): Metabolic effects of implantable steroid contraceptives for women, Contraception, (vol. 65), pp.47-62.

Druckmann R, Rohr UD (2002): IGF-I in gynaecology and obstetrics: update 2002, Maturitas, (vol. 41), No. Suppl 1, pp.S65-S83.

Duffy TJ, Ray R (1984): Oral contraceptive use: prospective follow-up of women with suspected glucose intolerance, Contraception, (vol. 30), pp.197-208.

Dunaif A (1979): Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus, Am J Med, (vol. 98), No. Suppl 1A, pp.33S-39S.

Dunaif A (1992): Insulin resistance and ovarian hyperandrogenism, The Endocrinologist, (vol. 2), pp.248-260.

Dunaif A (1997): Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis, Endocr Rev, (vol. 18), pp.774-800.

Dunaif A, Finegood DT (1996): Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 81), pp.942-947.

Dunaif A, Graf M (1989): Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistance women with polycystic ovary syndrome, J Clin Invest, (vol. 83), pp.23-29.

Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A (1987): Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia, J Clin Endocrinol Metab, (vol. 65), pp.499-507.

Dunaif A, Green G, Futterweit W, Dobrjansky A (1990): Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 70), pp.699-704.

Dunaif A, Scott D, Finegood DT, Quintana B, Whitcomb R (1996): The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 81), pp.3299-3306.

Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989): Profound insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, (vol. 38), pp.1165-1174.

Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T (1992): Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome, Diabetes, (vol. 41), pp.1257-1266.

Dunaif A, Thomas A (2001): Current concepts in the polycystic ovary syndrome, Annu Rev Med, (vol. 52), pp.401-419.

Dunaif A, Xia J, Book C, Schenker E, Tang Z (1995): Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome, J Clin Invest, (vol. 96), pp.801-810.

Dunger DB, Edge JA (1995): Glucose homeostasis in the normal adolescent, CJH, Kelnar, Ed, Childhood and adolescent diabetes, 1 ed. ed., pp. 31-45, Chapman & Hall Medical, London.

Dunn CJ, Peters DH (1995): Metformin: a review of its pharmacological properties and therapeutic uses in non-insulin dependent diabetes, Drugs, (vol. 49), pp.721-749.

Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF (1997): Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies, Diabetes, (vol. 46), pp.701-710.

Eden JA, Place J, Carter GD, Alaghband-Zadeh J, Pawson M (1989): Is the polycystic ovary a cause of infertility in the ovulatory woman?, Clin Endocrinol (Oxf), (vol. 30), pp.77-82.

Edge JA, Harris DA, Phillips PE, Pal BR, Matthews DR, Dunger DB (1993): Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents, Diabetes Care, (vol. 16), pp.1011-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8359093

Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J (2002): Inhibitory effects of ghrelin on insulin and pancreatic somatostatin secretion, Eur J Endocrinol, (vol. 146), pp.241-244.

Ehrmann DA, Barnes RB, Rosenfield RL, et al (1999): Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 81), pp.942-947.

Ehrmann DA, Cavaghan MK, Imperial J, et al (1997): Effects of metformin on insulin secretion, insulin action , and ovarian steroidogenesis in women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 82), pp.524-530.

Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS (1997): Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 82), pp.2108-2116.

Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS (1995): Insulin sercetory defects in polycystic ovary syndrome. Relationship to insulin sensitvity and family history of non-insulin-dependent diabetes mellitus, J Clin Invest, (vol. 96), pp.520-527.

El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts Jr. CT, Yen SS (1993): Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and the insulin receptor genes and localization of the gene products in the human ovary, J Clin Endocrinol Metab, (vol. 77), pp.1411-1418.

El-Roeiy A, Chen X, Roberts VJ, Shimasaki S, Ling N, LeRoith D, Roberts Jr. CT, Yen SS (1994): Expression of the genes encoding the insulin-like growth factors (IGF-I and IGF-II), the IGF and insulin receptor, and IGF-binding proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries, J Clin Endocrinol Metab, (vol. 78), pp.1488-1496.

Elahi D, Meneilly GS, Minaker KL, Andersen DK, Rowe JW (1989): Escape of hepatic glucose production during hyperglycemic glucose clamp, Am J Physiol, (vol. 257), pp.E704-E711.

Elkind-Hirsch KE, Sherman LD, Malinak LR (1993): Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure, J Clin Endocrinol Metab, (vol. 76), pp.472-475.

Elkind-Hirsch KE, Valdes CT, Malinak LR (1993): Insulin resistance improves in hyperandrogenic women treated with Luperon, Fertil Steril, (vol. 60), pp.634-641.

Elkind-Hirsch KE, Valdes CT, McConnel TG, et al (1991): Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women, Fertil Steril, (vol. 55), pp.486-491.

Erickson GF, Garzo VG, Magoffin DA, (1991): Progesterone production by human granulosa cells cultured in serum free medium: effects of gonadotrophins and insulin-like growth factor I (IGF-I)., Hum Reprod, (vol. 6), pp.1074-1081.

Erickson GF, Magoffin DA, Cragun JR, Chang RJ, (1990): The effects of insulin and insulin-like growth factors-I and -II on estaradiol production by granulosa cells of polycystic ovaries., J Clin Endocrinol Metab, (vol. 70), pp.894-902.

Ericksson J, Forsen T, Tuomilehhto J, Osmond C, Barker D (2001): Size at birth, childhood growth and obesity in adult life, Int J Obes Relat Metab Disord, (vol. 25), pp.735-740.

Eriksson KF, Lindgarde F (1991): Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical activity: the 6-year Malmo feasibility study, Diabetologia, (vol. 34), pp.891-898.

Eriksson KF, Taimela S, Koivisto VA, (1997): Exercise and the metabolic syndrome, Diabetologia, (vol. 40), pp.125-135.

Escalante Pulido JM, Alpizar Salazar M (1999): Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle, Arch Med Res, (vol. 30), pp.19-22.

Espeland MA, Hogan PE, Finberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL (1998): Effect of postmenopausal hormone therapy on glucose and insulin concentrations, Diabetes Care, (vol. 21), pp.1589-1595.

Ezenwaka EC, Akanji AO, Adejuwon CA, Abbiyesuku FM, Akinlade KS (1993): Insulin responses following glucose administration in menstruating women, Int J Gynaecol Obstet, (vol. 42), pp.155-159.

Fagan TC, Deedwania PC (1998): The Cardiovascular Dysmetabolic Syndrome, Am J Med, (vol. 105), pp.S77-S82.

Fagot-Campagna A (2000): Emergence of type 2 diabetes mellitus in children: epidemiological evidence, J Pediatr Endocrinol Metab, (vol. 13), No. Suppl 6, pp.1395-1402.

Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan Km, (2000): Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective., J Pediatr, (vol. 136), pp.664-672.

Fahmy K, Abdel-Razik M, Shaaraway M, al-Kohly G, Saad S, Wagdi A, al-Azzony M (1991): Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile, Contraception, (vol. 44), pp.419-430.

Farquhar CM, Birdsall M, Manning P, et al (1994): The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women, Aust N Z J Obstet Gynecol, (vol. 34), pp.67-72.

Fehmann HC, Habener JF (1992): Insulinotropic hormone Glucagon-like peptide -1 (7-37) stimaulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma ßTC-1 cells., Endocrinology, (vol. 130), pp.159-166.

Fendri S, Arlot S, Marcelli JM, Dubreuil A, Lalau JD, (1994): Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women., Int J Obes Relat Metab Disord, (vol. 18), pp.755-759.

Ferrannini E, Balkau B (2002): Insulin: in search of a syndrome, Diabet Med, (vol. 19), pp.724-729.

Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL (1995): Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study 1984-1987, Diabetes Care, (vol. 18), pp.220-225.

Ferrara A, Hedderson MM, Quesenberry CP, Selby JV (2002): Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds, Diabetes Care, (vol. 25), pp.1625-1630.

Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV (2001): Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry, Diabetes Care, (vol. 24), pp.1144-1150.

Festa A, Shnawa N, Krugluger W, Hopmeier P, Schernthaner G, Haffner SM (1999): Relative hypoleptinaemia in women with mild gestational diabetes mellitus, Diabet Med, (vol. 16), pp.656-662.

Filicori M, Flagmini C, Dellai P, et al (1994): Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles, J Clin Endocrinol Metab, (vol. 79), pp.1215-1220.

Fineberg SE (2000): Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study, Drugs Aging, (vol. 17), pp.453-461.

Fleming R, Hopkinson ZW, Wallace RE, Greer IA, Sattar N (2002): Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind, placebo-controlled trial, J Clin Endocrinol Metab, (vol. 87), pp.569-574.

Flier JS (2001): Diabetes. The missing link with obesity?, Nature, (vol. 409), pp.292-293.

Foley JE, Kashiwagi A, Chang H, Huecksteadt TP, Lillioja S, Verso MA, Reaven G (1984): Sex differences in insulin-stimulated glucose transport in rat and human adipocytes, Am J Physiol, (vol. 246), pp.E211-E215.

Folsom AR, Jacobs DR Jr., Wagenknecht LE, Winkhart SP, Yunis C, Hilner JE, Savage PJ, Smith DE, Flack JM (1996): Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults, Am J Epidemiol, (vol. 144), pp.235-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8686692

Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. (1997): A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study, Diabetes Care, (vol. 20), pp.935-942.

Ford ES, Giles WH, Dietz WH (2002): Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey, JAMA, (vol. 287), pp.356-359.

Forson T, Eriksson J, Toumilehto J, Reunanen A, Osmond C, Barker D, (2001): The fetal and childhood growth of persons who develop type 2 diabetes., Ann Intern Med, (vol. 133), pp.176-182.

Fox JH, Licholai T, Green G, Dunaif A (1993): Differential effects of oral glucose-mediated vs. intravenous hyperinsulinemia on circulating androgen levels in women, Fertil Steril, (vol. 60), pp.994-1000.

Franks S (1995): Medical Progress. Polycystic ovary syndrome, N Engl J Med, (vol. 333), pp.853-861.

Franks S, Gharani N, Waterworth D, et al (1997): The genetic basis of polycystic ovary syndrome, Hum Reprod, (vol. 12), pp.2641-2648.

Franssila-Kallunki A, Schalin-Jäntt C, Groop L (1992): Effect of gender on insulin resistance associated with aging., Am J Physiol, (vol. 263), pp.E780-E785.

Frayling TM, Lindgren CM, Chevre JC, Menzel S, Wishart M, Benmezroua Y, Brown A, Evans JC, Rao PS, Dina C, Lecoeur C, Kanninen T, Almgren P, Bulman MP, Wang Y, Mills J, Wright-Pascoe R, Mahtani MM, Prisco F, Costa A, Cognet I, Hansen T, Pedersen O, Ellard S, Tuomi T, Groop LC, Froguel P, Hattersley AT, Vaxillaire M. (2003): A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity, Diabetes, (vol. 52), pp.872-881.

Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS (2001): Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study, Pediatrics, (vol. 108), pp.712-718.

Freemark M, Bursey D (2001): The effects of Metformin on body mass index and glucose in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes, Pediatrics, (vol. 107), p.E55.

Friday KE, Dong C, Fontenot RU (2001): Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes, J Clin Endocrinol Metab, (vol. 86), pp.48-52.

Friedman JE, Ishizuka T, Shao J, Huston LP, Highman T, Jianhua S, Catalano PM (1999): Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle form obese women with gestational diabetes, Diabetes, (vol. 48), pp.1807-1814.

Frisch RE (1980): Pubertal adipose tissue: is it necessary for normal sexual maturation? Evidence from the rat an human female, Fed Proc, (vol. 39), pp.2395-2400.

Frisch RE, Reville R (1970): Height and weight at menarche and a hypothesis of critical body weights and adolescent events, Science, (vol. 169), pp.397-399.

Frisch RE, Wyshak G, Albright TE, Albright ML, Schiff L (1986): Lower prevalence of diabetes in female former college athletes compared with nonathletes., Diabetes, (vol. 35), pp.1101-1105.

Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD, (1994): The visceral adiposity syndrome in Japanese-American men, Obes Res, (vol. 2), pp.364-371.

Fulghesu A, Lanzone A, Andreani CL, Pierro E, Caruso A, Mancuso S (1995): Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease, Fertil Steril, (vol. 64), pp.703-708.

Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen HC (1980): Coronary-heart-disease risk and impaired glucoes tolerance: the Whitehall Study, Lancet, (vol. i), pp.1373-1376.

Futterweit W (1999): Polycystic ovary syndrome: Clinical perspectives and management, Obstet Gynecol Surv, (vol. 54), pp.403-413.

Gabal LL, Goodman-Gruen D, Barrett-Connor E (1997): The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus, AM J Public Health, (vol. 87), pp.443-445.

Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rosetti L, Barzilai N (2002): Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?, Diabetes, (vol. 51), pp.2951-2958. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12351432

Galante P, Mosthaf L, Kellerer M, Berti L, Tippmer S, Bossenmaier B, Fujiwara T, Okuno A, Horikoshi H, Haring HU (1995): Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C1C12 myotubes and rat skeletal muscle., Diabetes, (vol. 44), pp.646-651.

Galbraith HJ, Ginsburg J, Paton A (1960): Decreased response to intraarterial insulin in acromegaly, Diabetes, (vol. 9), p.459.

Gale EA, Gillespie KM (2001): Diabetes and gender, Diabetologia, (vol. 44), pp.3-15.

Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF, (1997): Serum leptin levels in normal children: relationship to age, gender body mass index, pituary gonadal hormones, and pubertal stage., J Clin Endocrinol Metab, (vol. 82), pp.2849-2855.

Garn SM, CLarrk DC (1975): Nutrition, growth, development, and maturation: findings form the ten-state nutrition survey of 1968-1970., Pediatrics, (vol. 56), pp.306-319.

Gaspard UJ (1987): Metabolic effects of oral contraceptives, Am J Obstet Gynecol, (vol. 157), pp.1029-1041.

Gaspard UJ, Gottal J-M, van den Brule FA, (1995): Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects, Maturitas, (vol. 21), pp.171-178.

Gaspard UJ, Lefebvre PJ (1990): Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease, Am J Obstet Gynecol, (vol. 163), pp.334-343.

Gautier J-F, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE (1999): Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion, Diabetologia, (vol. 42), pp.28-34.

Gautier J-F, Wilson C, Weyer C, Mott D, Knowler WC, Cavaghan M, Polonsky KS, Bogardus C, Pratley RE (2001): Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes, Diabetes, (vol. 50), pp.1828-1833.

Geffner ME, Kaplan SA, Bersch N, Golde DW, Landew EM, Chang RJ (1986): Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion, Fertil Steril, (vol. 45), pp.327-333.

Gerich JE (1998): The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity, Endocr Rev, (vol. 19), pp.491-503.

Gershberg H, Javier Z, Hulse M (1964): Glucose tolerance in women recieving an ovulating suppressant, Diabetes, (vol. 13), pp.378-382.

Givens JR, Kerber IJ, Wiser WL, et al (1974): Remissions of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma, J Clin Endocrinol Metab, (vol. 38), pp.347-355.

Gleason CE, Gonzalez M, Harmon JS, Robertson RP, (2000): Determinants of glucose toxicity and its reversibility in the pancreatic islet ß-cell line, HIT-T15, Am J Physiol Endocrinol Metab, (vol. 279), pp.E997-E1002.

Glueck CJ, Goldenberg N, Streicher P, Wang P (2002): The continuous nature of gestational diabetes: diet, insulin, glyburide, metformin, Expert Opin Pharmacother, (vol. 3), pp.1557-1568.

Glueck CJ, Phillips H, Cameron D, Sieve-Smith L,Wang P (2001): Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study, Fertil Steril, (vol. 75), pp.46-52.

Glueck CJ, Sieve-Smith L, Goldenberg N, Wang P (2002): Metformin improves pregnancy outcomes in 295 women (328 pregnancies) with polycystic ovary syndrome, J Invest Med, (vol. 50), pp.163-.

Glueck CJ, Wang P, Fontaine R, et al (1999): Metformin-induced resumption of normal menses in 39 out of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome, Metabolism, (vol. 48), pp.511-519.

Glueck CJ, Wang P, Gartside PS, et al (2001): Progression of morbid obesity in women with polycystic ovary syndrome and amelioration with metformin, J Invest Med, (vol. 49), pp.201-.

Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L (2002): Pregnancy outcomes among women with polycystic ovarian syndrome treated with metformin, Hum Reprod, (vol. 17), pp.2858-2864.

Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L (2002): Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome, Fertil Steril, (vol. 77), pp.520-525.

Godsland IF (1996): The influence of female sex steroids on glucose metabolism and insulin action, J Intern Med, (vol. 240), No. Suppl 738, pp.1-60.

Godsland IF (1996): Sex steroids and changes in the cardiovascular system: carbohydrate metabolism, Gynecol Endocrinol, (vol. 10), No. Suppl 2, pp.59-64.

Godsland IF, Crook D (1994): Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk, Am J Obstet Gynecol, (vol. 70), pp.1528-1536.

Godsland IF, Crook D, Devenport M, Wynn V (1995): Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease, Contraception, (vol. 52), pp.143-149.

Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V (1990): The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism, N Engl J Med, (vol. 323), pp.1375-1381.

Godsland IF, Crook D, Stevenson JC, Collins P, Rosano GMC, Lees B, Sidhu M, Poole-Wilson PA (1995): The insulin resistance syndrome in postmenopausal women with cardiological syndrome X, Br Heart J, (vol. 74), pp.47-52.

Godsland IF, Crook D, Wynn V (1990): Low-dose oral contraceptives and carbohydrate metabolism, Am J Obstet Gynecol, (vol. 163), pp.348-353.

Godsland IF, Ganger K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC (1993): Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy, Metabolism, (vol. 42), pp.846-853.

Godsland IF, Shennan NM, Wynn V (1986): Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (DianabolR), Clin Sci, (vol. 71), pp.665-673.

Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V (1992): Insulin resistance, secretion, and metabolism in users of oral contraceptives, J Clin Endocrinol Metab, (vol. 74), pp.64-70.

Goldman J (1975): Effect of ethynodiol diacetate and combination type oral contraceptive compounds on carbohydrate metabolism. Six months intraceous glucose tolerance study, Diabetologia, (vol. 11), pp.45-48.

Goldman JA, Eckerling B (1970): Glucose metabolism during the menstrual cycle, Obstet Gynecol, (vol. 35), pp.207-210.

Goodpaster BH, Kelley DE, Wing RR, Meier A, Theate FL (1999): Effects of weight loss on regional fat distribution and insulin sensitivity in obesity, Diabetes, (vol. 48), pp.839-847.

Goran MI (1998): Measurement issues related to studies of childhood obesity; assessment of body composition, body fat distribution, physical activity and food intake., Pediatrics, (vol. 101), No. Suppl 3, pp.505-518.

Goran MI (2001): Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999., Am J Clin Nutr, (vol. 73), pp.158-171.

Goran MI, Bergmann RN, Gower BA (2001): Influence of total vs visceral fat on insulin action and secretion in African American and white children., Obes Res, (vol. 9), pp.423-31.

Goran MI, Gower BA (2001): Longitudinal study on pubertal insulin resistance, Diabetes, (vol. 50), pp.2444-2450.

Gordon T, Kannel WB, Hjortland MC, McNamara PM (1978): Menopause and coronary heart disease. The Framingham Study, Ann Intern Med, (vol. 89), pp.157-161.

Göretzlehner G, Rudolf K (1979): Hormonale Kontrazeptiva und Kohlenhydratstoffwechsel, Dtsch Gesundheitswesen, (vol. 34), pp.1393-1398.

Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH, (1993): Social and economic consequences of overweight in adolescents and young adulthood., N Engl J Med, (vol. 329), pp.1008-1012.

Gossain VV, Sherma NK, Michelakis AM, Rovner DR, (1983): Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels, Am J Obstet Gynecol, (vol. 147), pp.618- 623.

Grady D, Wenger JK, Herrington D, Khan S, Furberg C, Hunninghake D, et al (2000): Postmenopausal hormone therapy increases the risk for venous thromboembolic disease, Ann Intern Med, (vol. 132), pp.689-696.

Grant DB (1967): Fasting serum insulin levels in childhood, Arch Dis Child, (vol. 375), p.378.

Griffin M, Heaton DA, McEwan JA (1988): Long-term use of an injectable contraceptive: effect of depot-norethisterone oenanthate on carbohydrate metabolism, Contraception, (vol. 37), pp.53-60.

Grodstein F, Goldman MB, Cramer DW (1994): Body mass index and ovulatory infertility, Epidemiology, (vol. 5), pp.247-250.

Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A (2002): Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys, J Clin Endocrinol Metab, (vol. 87), pp.1162-1169.

Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A (2003): Relationship between the growth hormone/ insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls, J Clin Endocrinol Metab, (vol. 88), pp.1389-1393.

Guerrero-Romero F, Rodriguez-Moran M (2001): Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose, Journal of Diabetes and its Complications, (vol. 15), pp.34-37. http://www.sciencedirect.com/science/article/B6T88-42JYTV5-V/2/d698722deee8a592eeaa1bb46e1ea822

Gunton JE, Hitchman R, McElduff A (2001): Effects of ethnicity on glucose tolerance, insulin resistance, and beta cell function in 223 women with an abnormal challenge test during pregnancy, Aust NZ J Obstet Gynecol, (vol. 41), pp.182-186.

Guo SS, Roche AF, Chumela WC, (1994): The predictive value of childhood body mass index values for overweight at age 35 yrs., Am J Clin Nutr, (vol. 59), pp.810-819.

Gurgan T, Bukulmez O, Yarli H, Tanir M, Akyildiz S (1999): Serum and peritoneal fluid levels of IGF-I and II and insulin-like growth factor binding protein-3 in endometriosis, J Reprod Med, (vol. 44), pp.450-454.

Haarbo J, Marslew U, Gotfredsen A, Christiansen C (1991): Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause, Metabolism, (vol. 40), pp.1323-1326.

Haffner SM, D´Agostino R, Saad MF, et al (1996): Increased insulin resistance and insulin secretion in non-diabetic African-American and Hispanics compared with non-Hispanic whites: The Insulin Resistance in Atherosclerosis Study, Diabetes, (vol. 45), pp.742-748.

Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995): Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans, Diabetes, (vol. 44), pp.1386-1391.

Haffner SM, Miettinen H, Gaskill SP, Stern MP (1996): Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance, Diabetologia, (vol. 39), pp.1201-1207.

Haffner SM, Mitchell BD, Hazuda HP, Stern MP (1991): Greater influence of central distribution of adipose tissue on incidence of type 2 diabetes in women than in men, Am J Clin Nutr, (vol. 53), pp.1312-1317.

Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL (1996): Leptin concentrations in diabetic and nondiabetic Mexican-Americans, Diabetes, (vol. 45), pp.822-824.

Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992): Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes, (vol. 41), pp.715-722.

Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP (1993): Decreased sex hormone binding globulin predicts non-insulin-dependent diabetes mellitus in women but not in men, J Clin Endocrinol Metab, (vol. 77), pp.56-60.

Hamilton GD, Bronson FH (1986): Food restriction and reproductive development: male and female mice and male rats, Am J Physiol, (vol. 250), pp.R370-R376.

Hamman RF (1992): Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM), Diabetes Metab Rev, (vol. 8), pp.287-338.

Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT (1979): Effects of long-term estrogen replacement therapy. I. Metabolic effects, Am J Obstet Gynecol, (vol. 133), pp.525-536.

Hanefield M, Temelkova-Kurtschiev T (1997): The postprandial state and the risk of atherosclerosis, Diabet Med, (vol. 14), pp.S6-S11.

Hanggi W, Lippuner K, Jaeger P, Birkhauser MH, Horber FF (1998): Differential impact on conventional oral or transdermal hormone replacement therapy or tibolone on body composition in Postmenopausal women, Clin Endocrinol (Oxf), (vol. 48), pp.691-699.

Hannaford PC, Kay CR (1989): Oral contraceptives and diabetes mellitus, BMJ, (vol. 299), pp.1315-1316.

Harper MA, Meis PJ, Steele L (1997): A prospective study of insulin sensitivity and glucose metabolism in women using a continuous subdermal levonorgestrel implant system, J Soc Gynecol Investig, (vol. 4), pp.86-89.

Harris MI (1989): Impaired glucose tolerance in the U.S. population, Diabetes Care, (vol. 12), pp.464-474.

Harris MI (1993): Undiagnosed NIDDM: clinical and public health issues, Diabetes Care, (vol. 16), pp.642-653.

Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H-S, Byrd-Holt DD (1998): Prevalence of diabetes, impaired fasting glucose, and glucose tolerance in U.S. adults, Diabetes Care, (vol. 21), pp.518-524.

Harris MI, Hadden WC, Knowler WC, Bennett PH (1987): Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74, Diabetes, (vol. 36), pp.667-687.

Harris MI, Klein R, Welborn TA, Knuiman WM (1992): Onset NIDDM occurs at least 4-7 yr before clinical diagnosis, Diabetes Care, (vol. 15), pp.815-819.

Hartz AJ, Barboriak PN, Wong A, Katayama KP (1979): The association of obesity with infertility and related menstrual abnormalities in women, Int J Obesity, (vol. 3), pp.57-60.

Harvengt C (1992): Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus, Diabete Metab, (vol. 18), pp.71-77.

Hatasaka H, Kaser R, Chatterton R, Unterman T, Glick R (1994): The response of the growth hormone and insulin-like growth factor I axis to medical castration in women with polycystic ovary syndrome, Fertil Steril, (vol. 62), pp.273-278.

Hauner H (1998): Occurence of diabetes mellitus in Germany, Dtsch Med Wochenschr, (vol. 123), pp.777-782.

Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J (1995): Effects of tumor necrosis factor a (TNFa) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture, Diabetologia, (vol. 38), pp.764-771.

Hauner H, von Ferber L, Köster I (1992): Schätzung der Diabeteshäufigkeit in der Bundesrepublik Deutschland anhand von Krankenkassendaten., Dtsch Med Wochenschr, (vol. 117), pp.645-650.

Heding LG, Perrson B, Strangenberg M (1980): b-cell function in newborn infants of diabetic mothers, Diabetologia, (vol. 19), pp.427-430.

Hemminki R, McPherson K (2000): Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease, Lancet, (vol. 355), pp.566-569.

Henriksen JE, Alford F, Handberg A, Ward GM, Kalfas A, Beck-Nielsen H, (1994): Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus., J Clin Invest, (vol. 94), pp.1196-1204.

Henry RR (1997): Thiazolidinediones, Endocrinol Metab Clin North Am, (vol. 26), pp.553-573.

Henson MC, Castracane VD (2000): Leptin in pregnancy, Biol Reprod, (vol. 63), pp.1219-1228.

Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, LeRoith D (1992): Expression of the genes encoding insulin-like growth factors and their receptors in the human ovary., J Clin Endocrinol Metab, (vol. 74), pp.419-425.

Hiltunen L, Luukinen H, Koski K, Kivlä SL (1994): Prevalence of diabetes mellitus in an elderly Finnish population, Diabetic Med, (vol. 11), pp.241-249.

Hindmarsh P, Di Silvio L, Pringle PJ, Kurtz AB, Brook CG (1988): Changes in serum insulin concentration during puberty and their relationship to growth hormone, Clin Endocrinol (Oxf), (vol. 28), pp.381-388. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3056636

Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987): Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations, J Clin Endocrinol Metab, (vol. 64), pp.51-58. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3782436

Hoffman RP, Vicini P, Sivitz WI, Cobelli C (2000): Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model, Pediatr Res, (vol. 48), pp.384-388.

Hofmann E (1999): Medizinische Biochemie systematisch, 2. Auflage. ed., Uni-Med, Lorch.

Hollenbeck C, Reaven GM (1987): Variations in insulin--stimulated glucose uptake in healthy individuals with normal glucose tolerance, J Clin Endocrinol Metab, (vol. 64), pp.1169-1173.

Holness MJ, Munns MJ, Sugden MC (1999): Current concepts concerning the role of leptin in reproductive function, Mol Cell Endocrinol, (vol. 157), pp.11-20.

Holte J, Bergh T, Berne C, Berglund L, Lithell H (1994): Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance, J Clin Endocrinol Metab, (vol. 78), pp.1052-1058.

Holte J, Bergh T, Berne C, Lithell H (1994): Serum lipoprotein lipid profile in women with polycystic ovary syndrome: Relation to anthropometric, endocrine and metabolic variables, Clin Endocrinol (Oxf), (vol. 41), pp.463-471.

Holte J, Bergh T, Berne C, Wide L, Lithell H (1995): Restored insulin sensitivity bur persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 82), pp.556-560.

Holte J, Gennarelli G, Wide L, Lithell H, Berne C (1998): High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus, J Clin Endocrinol Metab, (vol. 83), pp.1143-1150.

Homburg R (1996): Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy, Hum Reprod, (vol. 11), pp.29-39.

Homburg R (2002): What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnoses of polycystic ovarian syndrome, Hum Reprod, (vol. 17), pp.2495-2499.

Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS (1988): Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in the polycystic ovary syndrome, Br Med J, (vol. 297), pp.1024-1026.

Hotamisligil GS, Arner P, Atkinson RL, Spiegelmann BM (1997): Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance, Diabetes, (vol. 46), pp.451-455.

Howe G, Westhoff C, Vessey M, Yeates D (1985): Effects of age, cigeratte smoking, and other factors on fertility: findings in a large prospective study, Br Med J, (vol. 290), pp.1697-1700.

Hsueh AJ, Billig H, Tsafriri A (1994): Ovarian follicle atresia: a hormonally controlled apoptotic process, Endocr Rev, (vol. 15), pp.707-724.

Huang JC, Papasakelariou C, Yussoff Dawood M (1996): Epidermal growth factor and basic fibroblast growth factor peritoneal fluid of women with endometriosis, Fertil Steril, (vol. 65), pp.931-934.

Huang TT, Johnson MS, Gower BA, Goran MI (2002): Effect of changes in fat distribution on the rates of change of insulin response in children, Obes Res, (vol. 10), pp.978-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12376577

Hube F, Hauner H (1999): The role of TNF-alpha in human adipose tissue: Prevention of weight gain at the expense of insulin resistance?, Horm Metab Res, (vol. 31), pp.626-631.

Hubert HB, Feinlieb M, McNamara PM, Castelli WP, (1983): Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study., Circulation, (vol. 67), pp.968-977.

Hui H, Yu R, Bousquet C, Perfetti R (2002): Transfection of Pancreatic-Derived {beta}-Cells with a Minigene Encoding for Human Glucagon-Like Peptide-1 Regulates Glucose-Dependent Insulin Synthesis and Secretion, Endocrinology, (vol. 143), pp.3529-3539. http://endo.endojournals.org/cgi/content/abstract/143/9/3529

Hull MG (1987): Epidemiology of infertility and polycystic ovarian disease: endocrinological an demographic studies, Gynecol Endocrinol, (vol. 1), pp.235-245.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al (1998): Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, (vol. 280), pp.605-613.

Hulman S, Brodsky N, Miller J, Donnelly C, Helms J, Falkner B (1996): Effect of estrogen withdrawal on bloodpressure and insulin resistance in sucrose-fed juvenile rats, Am J Hypertens, (vol. 9), pp.1200-1205.

Hultquist GT, Olding LB (1975): Pancreatic-islet fibrosis in young infants of diabetic mothers, Lancet, (vol. ii), pp.1015-1018.

Ibanez L, Dimartino-Nardi J, Potau N, Saenger P (2000): Premature adrenarche-normal variant or forerunner of adult disease?, Endocr Rev, (vol. 21), pp.671-696.

Imbeault P, Prins JB, Stolic M, Russell AW, O´Moore-Sullivan T, Després J-P, Bouchard C, Trmblay A (2003): Aging per se does not influence glucose homeostasis: in vivo an in vitro evidence, Diabetes Care, (vol. 26), pp.480-484.

Invitii C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003): Prevalence and concomitants of glucose intolerance in European obese children and adolescents, Diabetes Care, (vol. 26), pp.118-124.

Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Järvinen H, Ferrannini E (1999): Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance, J Clin Endocrinol Metab, (vol. 84), pp.863-868.

Iuorno MJ, Nestler JE (2001): Insulin-lowering drugs in polycystic ovary syndrome, Endocrinol Metab Clin North Am, (vol. 28), pp.153-164.

Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE (2002): Effects of metformin on early pregnancy, loss in the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 87), pp.524-529.

Jakubowicz DJ, Nestler JE (1997): 17a- Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss, J Clin Endocrinol Metab, (vol. 82), pp.2586-2593.

Janssen RC, Bogardus C, Takeda J, Knowler WC, Thompson DB (1994): Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2, Diabetes, (vol. 43), pp.558-563.

Jarrett RJ, Graver HJ (1968): Changes in oral glucose tolerance during the menstrual cycle, Br J Med, (vol. 1), pp.528-529.

Jensen J, Riis BJ, Strom V, et al (1987): Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women, Am J Obstet Gynecol, (vol. 156), pp.66-71.

Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS (1996): Racial (black-white) differences in insulin secretion and clearance in adolescents: the Bogalusa Heart Study, Pediatrics, (vol. 97), pp.357-360.

Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A (1987): Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity, J Clin Endocrinol Metab, (vol. 64), pp.661-668.

Joffe GM, Esterlitz JR, Levine RJ, et al (1998): The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women, Am J Obstet Gynecol, (vol. 174), pp.1032-1037.

Johnson MS, Figueroa-Colon R, Huang T, Dweyer JH, Goran MI (2001): Longitudinal changes in body fat in African American and Caucasian children: influence of fasting insulin and insulin sensitivity, J Clin Endocrinol Metab, (vol. 86), pp.3182-3187.

Jones CNO, Abbasi F, Carantoni M, Polonsky KS, Reaven GM (2000): Roles of insulin resistance and obesity in regulation of plasma insulin concentrations, Am J Physiol Endocrinol Metab, (vol. 278), pp.E501-508. http://ajpendo.physiology.org/cgi/content/abstract/278/3/E501

Jones CNO, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM (1997): Alterations in the Glucose-Stimulated Insulin Secretory Dose-Response Curve and in Insulin Clearance in Nondiabetic Insulin-Resistant Individuals, J Clin Endocrinol Metab, (vol. 82), pp.1834-1838. http://jcem.endojournals.org/cgi/content/abstract/82/6/1834

Juhan-Vague I, Alessi MC, Vague P (1991): Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis, Diabetologia, (vol. 34), pp.457-462.

Kadowaki T (2000): Insights into insulin resistance and type 2 diabetes from knockout mouse model, J Clin Invest, (vol. 106), pp.459-465.

Kahn BB (1998): Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance,, Cell, (vol. 92), pp.593-596.

Kahn CR (1994): Banting lecture: Insulin action, diabetogenes, and the cause of type 2 diabetes, Diabetes, (vol. 43), pp.1066-1084.

Kahn SE, Larson VG, Schwartz RS, Beard JC, Cain KC, Fellingham GW, Veith RC, Stratton JR, Cerqueira MD, Abrass IB (1990): Effect of exercise on insulin action, glucose tolerance and insulin secretion in aging, Am J Physiol, (vol. 258), pp.E937-E943.

Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergmann RN, Schwartz MW, Neifing JL, Ward WK, Beard JP, Palmer JP, Porte D Jr. (1994): The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects, Diabetes, (vol. 43), pp.587-592.

Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D (2001): Obesity, body fat distribution, insulin sensitivity and islet ß-cell function as explanation for metabolic diversity, J Nutr, (vol. 131), No. Suppl, pp.S354-S360.

Kalkhoff RK (1980): Relative sensitivity of postpartum gestational diabetic women to oral contraceptive agents and other metabolic stress, Diabetes Care, (vol. 3), pp.421-424.

Kalkhoff RK (1982): Metabolic effects of progesterone, Am J Obstet Gynecol, (vol. 142), pp.735-738.

Kalkhoff RK, Jacobsen M, Lemper D (1970): Progesterone, pregnancy and the augmented plasma insulin response, J Clin Endocrinol Metab, (vol. 31), pp.24-28.

Kamada S, Kubota T, Taguchi M, Ho WR, Sakamoto S, Aso T, (1992): Effects of insulin-like growth factor-II on proliferation adn differentiation of ovarian granulosa cells., Horm Res, (vol. 37), pp.141-149.

Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E (2003): Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study, Ann Intern Med, (vol. 138), pp.1-9.

Kaneto H, Kajimoto Y, Miyagawa J-i, Matsuoka T-a, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M (1999): Beneficial effects of antioxidants in diabetes. Possible protection of pancreatic b-cells against glucose toxicity, Diabetes, (vol. 48), pp.2398-2406.

Kannel WB (1987): Metabolic risk factors for coronary heart disease in women: perspectives from the Framingham Study, Am Heart J, (vol. 114), pp.413-429.

Kannel WB, McGee DL (1979): Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study., Diabetes Care, (vol. 2), pp.120-126.

Karlander S, Vranic M, Efendic S (1986): Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance, Diabetologia, (vol. 29), pp.778-783.

Kazer R (1989): The etiology of polycystic ovary syndrome (PCO), Med Hypotheses, (vol. 30), pp.151-155.

Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ (1999): Use of hormone replacement therapy by postmenopausal women in the United States, Ann Intern Med, (vol. 130), pp.545-553.

Kerrigan JR, Rogol AD (1992): The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence, Endocr Rev, (vol. 13), pp.281-298.

Khaw KT, Barrett-Connor E (1991): Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women, Clin Sci, (vol. 83), pp.489-494.

Kiddy DS, Hamilton-Fairley D, Bush A, et al (1992): Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome, Clin Endocrinol (Oxf), (vol. 36), pp.105-111.

Kiddy DS, Hamilton-Fairley D, Seppala M, Koistinen R, James VHT, Reed MJ, Franks S (1989): Diet-induced changes in sex-hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-1, Clin Endocrinol (Oxf), (vol. 31), pp.757-763.

Kim C, Lewis CE, Siscovick DS, Kiefe CI, Sidney S, Koepsell TD (2002): Oral contraceptive use and association with glucose, insulin, and diabetes young adult women. The CARDIA Study, Diabetes Care, (vol. 25), pp.1027-1032.

Kim C, Newton KM, Knopp RH (2002): Gestational diabetes and the incidence of type 2 diabetes. A systematic review, Diabetes Care, (vol. 25), pp.1862-1868.

Kim JG, Suh CS, Kim SH, Choi YM, Moon SY, Lee JY (2000): Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis, Fertil Steril, (vol. 73), pp.996-1000.

Kim SH, Ma X, Klupa T, Powers C, Pezzolesi M, Warram JH, Rich SS, Krolewski AS, Doria A (2003): Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24, Diabetes, (vol. 52), pp.2182-2186.

King H, Dowd JE (1990): Primary prevention of type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, (vol. 33), pp.3-8.

Kissebah AH (1992): Upper body obesity: Abnormalities in the metabolic profile and the androgenic/estrogenic balance, Dunaif A, Givens JR, Haseltine FP, Merriam GR, Ed, Polycystic ovary syndrome, pp. 359-374, Blackwell Scientific, Cambridge, MA.

Kissebah AH, Harrigan P, Wynn V (1973): Mechanism of hypertriglyceridaemia associated with contraceptive steroids, Horm Metab Res, (vol. 5), pp.184-190.

Kissebah AH, Preiris AN (1989): Biology of regional body fat distribution: relationship to non-inuslin-dependent diabetes mellitus., Diab Metab Rev, (vol. 15), pp.83-109.

Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW (1982): Realtion of body fat distribution to metabolic complications of obesity, J Clin Endocrinol Metab, (vol. 54), pp.254-260.

Kitagawa T, Owada M, Urakami T, Yamauchi K (1998): Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake in animal protein and fat, Clin Pediatr, (vol. 37), pp.111-115.

Kivelä A, Ruuskanen M, Agren U, Dieben T (2001): The effects of two progestogen-only pills containing either desogestrel (75µg/day) or levonorgestrel (30µg/day) on carbohydrate metabolism and adrenal and thyroid function, European Journal of Contraception and Reproductive Health Care, (vol. 6), pp.71-77.

Kjos SL (1996): Contraception in diabetic women, Obstet Gynecol Clin N Am, (vol. 23), pp.243-258.

Kjos SL, Buchanan TA (1999): Current concepts: Gestational diabetes mellitus, N Engl J Med, (vol. 341), pp.1749-1756.

Kjos SL, Peters RK, Xiang A, Henry OA, Montoro MN, Buchanan TA (1995): Predicting future diabetes Latino women with prior gestational diabetes: utility of early postpartum glucose tolerance testing, Diabetes, (vol. 44), pp.586-591.

Kjos SL, Peters RK, Xiang A, Schaefer U, Buchanan TA (1998): Hormonal choices after gestational diabetes: subsequent pregnancy, contraception, and hormone replacement, Diabetes Care, (vol. 21), No. Suppl 2, pp.B50-B57.

Kjos SL, Peters RK, Xiang A, Thomas D, Schaefer U, Buchanan TA (1998): Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus, JAMA, (vol. 280), pp.533-538.

Kjos SL, Shoupe D, Douyan S, Friedmann RL, Bernstein GS, Mestmann JH, Mishell DR Jr. (1990): Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study, Am J Obstet Gynecol, (vol. 163), pp.1822-1827.

Klein BEK, Moss SE, Klein R (1990): Oral contraceptives in women with diabetes, Diabetes Care, (vol. 13), pp.895-898.

Kneale BLG, Giles GG (1993): Endometrial cancer: Trends in the incidence and survival: a preventable disease, Aust NZ J Obstet Gynecol, (vol. 33), pp.1-7.

Knochenhauer ES, Key TJ, Kashar-Miller M, Waggoner W, Boots LR, Azzis R (1998): Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study, J Clin Endocrinol Metab, (vol. 83), pp.3078-3082.

Knopp RH, Broyles FE, Cheung M, Moore K, Marcovina S, Chandler WL (2001): Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel, Contraception, (vol. 63), pp.1-11.

Knowler WC, Bennett PH, Hamman RF, et al (1978): Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota, Am J Epidemiol, (vol. 108), pp.497-504.

Knowler WC, Pettitt DJ, Saad MF, Bennett PH, (1990): Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis, Diabetes Metab Rev, (vol. 6), pp.1-27.

Ko G, Chan J, Tsang L, Li C, Cockram C (1999): Glucose intolerance and other cardiovascular risk factors in Chinese women with a history of gestational diabetes mellitus, Aust N Z J Obstet Gynecol, (vol. 39), pp.478-483.

Koivunen R, Laatikainen T, Tomas C, Tapanainen J, Martikainen H (1999): The prevalence of polycystic ovaries in healthy women, Acta Obstet Gynecol Scand, (vol. 78), pp.137-141.

Kojima T, Lindheim SR, Duffy DM, Vijod MA, Stanczyk FZ, Lobo RA (1993): Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives, Am J Obstet Gynecol, (vol. 169), pp.1540-1544.

Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L (2000): Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome, Fertil Steril, (vol. 73), pp.1149-1154.

Koltermann OG, Insel J, Saekow M, Olefsky JM (1980): Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects, J Clin Invest, (vol. 65), pp.59-64.

Konje JC, Otolorin EO, Lapido OA (1991): Changes in carbohydrate metabolism during 30 months on Norplant, Contraception, (vol. 44), pp.163-172.

Konje JC, Otolorin EO, Lapido OA (1992): The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism, Am J Obstet Gynecol, (vol. 166), pp.15-19.

Koopersmith TB, Lobo RA (1995): Insulin sensitivity is unaltered by the use of the Norplant subdermal contraceptive, Contraception, (vol. 51), pp.197-200.

Korbonits M, Gueorguiev M, O´Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P (2002): A variation in ghrelin gene increases weight and decreases insulin secretion in tall, obese children, J Clin Endocrinol Metab, (vol. 87), pp.4005-4008.

Kousta E, Cela E, Lawrence NJ, Penny A, Millauer BA, White DM, Wilson H, Robinson S, Johnston DG, McCarthy MI, Franks S (2000): The prevalence of polycystic ovaries in women with a history of gestational diabetes, Clin Endocrinol (Oxf), (vol. 53), pp.501-507.

Kousta E, White DM, Cela E, McCarthy MI, Franks S (1999): The prevalence of polycystic ovaries in women with infertility, Hum Reprod, (vol. 14), pp.2720-2723.

Kowalska I, Kinalski M, Strazckowski M, Wolczyski S, Kinalska I (2001): Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome, Eur J Endocrinol, (vol. 144), pp.509-515.

Krauss RM (1991): The tangled web of coronary risk factors, Am J Med, (vol. 90), No. Suppl 2, pp.36-41.

Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg Henriksson H (1998): Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects, Diabetes, (vol. 47), pp.1281-1286.

Kruse-Jarres JD, Reinauer H, Witt I (1995): Kohlenhydratstoffwechsel, Greiling H, Gressner AM, Ed, Lehrbuch der Klinischen Chemie und Pathobiochemie (vol. 3. Auflage), pp. 247-298, Schaltauer Verlag.

Kuhl C (1998): Etiology and pathogenesis of gestational diabetes, Diabetes Care, (vol. 21), pp.B19-B26.

Kuhl H, Gahn G, Romberg G, Althoff P-H, Taubert H-D (1985): A randomized cross over comparison of tow low-dose oral contraceptives upon hormonal an metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance, Contraception, (vol. 32), pp.97-107.

Kuhl H, Taubert H-D (1996): Hormonelle Kontrazeption, HPG, Schneider, Ed, Empfängnisverhütung, pp. 1-64, Urban&Schwarzenberg, München-Wien-Baltimore.

Kumagai S, Holmang A, Björntorp P (1993): The effects of oestrogen and progesterone on insulin sensitivity in female rats, Acta Physiol Scand, (vol. 149), pp.91-97.

Kumar S, Boulton AJ, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P (1996): Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients: Troglitazone study group, Diabetologia, (vol. 39), pp.701-709.

Kung AW, Ma JT, Wong VC, Li DF, Ng NM, Wang CC, Lam KS, Young RT, Ma HK (1987): Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes, Contraception, (vol. 35), pp.257-269.

Kuusisto J, Mykknen L, Pyörälä K, Laasko M, (1994): NIDDM and its metabolic control predict coronary heart disease in elderly subjects., Diabetes, (vol. 43), pp.960-967.

Laakso M (1993): How good a marker is insulin levels for insulin resistance, Am J Epidemiol, (vol. 137), pp.959-965.

Lam K, Carpenter CL, Rudermann NB, Friel JC, Kelly KL (1994): The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1: stimulation by insulin and Wortmannin, J Biol Chem, (vol. 269), pp.20648-20652.

Landon MB, Gabbe SG, Sachs L (1990): Management of diabetes mellitus and pregnancy: a survey of obstetricians and maternal-fetal specialists, Obstet Gynecol, (vol. 75), pp.635-640.

Lang U, Feige A (2002): Diabetes mellitus und Gravidität, Bender HG, Diedrich K, Künzel W, Ed, Klinik der Frauenheilkunde und Geburtshilfe- Schwangerschaft II (vol. 5), Urban & Fischer, München Jena.

Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L (1984): Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population of Gothenburg, Sweden, Br J Med, (vol. 289), pp.1257-1261.

Lapidus L, Helgesson O, Merck C, Björntorp P (1988): Adipose tissue distribution and female carcinoma. A 12 years follow up of participants in the population study of women in Gothenburg, Sweden, Int J Obesity, (vol. 12), pp.361-368.

Lapidus L, Lindstedt G, Lundberg P-A, Bengtsson C, Gredmark T (1986): Concentrations of sex-hormone-binding globulin and corticosteroid-binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women, Clin Chem, (vol. 32), pp.146-152.

Larsson-Cohn U, Tengstrom B, Wide L (1969): Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment, Acta Endocrinol, (vol. 62), pp.242-250.

Law CM, Gordon GS, Shiell AW, Barker DJ, Hales CN (1995): Thinness at birth and glucose tolerance in seven-year-old children, Diabet Med, (vol. 12), pp.24-29.

Lawrenson RA, Newson RB, Feher MD (1998): Do women with diabetes recieve hormone replacement therapy?, Practical Diabetes Int, (vol. 15), pp.71-72.

Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N (2000): Placental leptin in normal, diabetic and fetal growth-retarded pregnancies, Mol Hum Reprod, (vol. 6), pp.763-769.

Lebovitz HE (2001): Insulin resistance: definition and consequences, Exp Clin Endocrinol Diabetes, (vol. 109), No. Suppl 2, pp.S135-48. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11460565

Legro RS, Kunselmann AR, Dodson WC, Dunaif A, (1999): Prevalence and predictors of risk of type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, J Clin Endocrinol Metab, (vol. 84), pp.165-169.

Legro RS, Spielman R, Urbanek M, et al (1998): Phenotype and genotype in polycystic ovary syndrome, Recent Prog Horm Res, (vol. 53), pp.217-256.

Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L, (2000): Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins, Diabetologia, (vol. 43), pp.285-293.

Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, Haugel-de Mouzon S (1998): Overexpression of placental leptin in diabetic pregnancy. A critical role for insulin, Diabetes, (vol. 47), pp.847-850.

LeRoith D (1997): Insulin-like growth factors, N Engl J Med, (vol. 336), pp.633-640.

LeRoith D, Werner H, Beitner-Johnson D, Roberts CT, (1995): Molecular and cellular aspects of the insulin-like growth factor I receptor., Endocr Rev, (vol. 16), pp.143-163.

Levitt NS, Lambert EV, Woods D, Hales CN, Andrew R, Seckl JR (2000): Impaired glucose tolerance and elevated blood pressure in low birth weight , nonobese, young south african adults: early programming of cortisol axis, J Clin Endocrinol Metab, (vol. 85), pp.4611-4618.

Lewy VD, Danadian K, Witchel SF, Arslanian S (2001): Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome, J Pediatr, (vol. 138), pp.38-44.

Ley CJ, Swan J, Godsland IF, et al (1994): Insulin resistance, lipoproteins, body fat and hemostasis in non-obese males with angina and normal or abnormal coronary angiograms, Journal of the American College of Cardiologists, (vol. 23), pp.377-383.

Li C, Johnson MS, Goran MI (2001): Effects of low birth weight on insulin resistance syndrome in caucasian and African- American children, Diabetes Care, (vol. 24), pp.2035-2042.

Li C, Samsioe G, Borgfeldt C, Bendahl P-O, Wilawan K, Aberg A (2003): Low-dose hormone therapy and carbohydrate metabolism, Fertil Steril, (vol. 79), pp.550-555.

Libman I, Arslanian SA (1999): Type II diabetes mellitus: no longer just adults, Pediatr Ann, (vol. 28), pp.589-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10496001

Liew DF, Ng CS, Heng SH, Ratnam SS (1986): A comparative study of the metabolic effects of injectable and oral contraceptives, Contraception, (vol. 33), pp.385-394.

Lillioja S, Mott DM, Spraul M, et al (1993): Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians, N Engl J Med, (vol. 329), pp.1988-1992.

Lillioja S, Nyomba BL, Saad MF (1991): Exaggerated early insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians, J Clin Endocrinol Metab, (vol. 73), pp.866-876.

Lindheim SR, Duffy DM, Kojima T, Vijod MA, Stanczyk FZ, Lobo RA (1994): The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women, Fertil Steril, (vol. 62), pp.1176-1180.

Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA (1993): A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin, Fertil Steril, (vol. 60), pp.664-667.

Lindstedt G, Lundberg P-A, Lapidus L, Lundgren H, Bengtsson C, Björntorp P (1991): Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-year follow-up of population study of women in Gothenburg, Sweden, Diabetes, (vol. 40), pp.123-128.

Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA (1996): Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years, BMJ, (vol. 312), pp.406-410.

Lithell HO, Weiner E, Vessby B, Johansson ED (1983): Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women, Ups J Med Sci, (vol. 88), pp.103-108.

Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J (1998): Tumor necrosis factor-a acutely inhibits insulin signaling in human adipocytes: Implication of the p80 tumor necrosis factor receptor, Diabetes, (vol. 47), pp.515-522.

Livingstone C, Collison M (2002): Sex steroids and insulin resistance, Clin Sci, (vol. 102), pp.151-166.

Lobo RA, Bush T, Carr BC, Pickar JH (2001): Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoprotein, coagulation factors, and carbohydrate metabolism, Fertil Steril, (vol. 76), pp.13-24.

Lobo RA, Goebelsmann U, Horton R (1983): Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 57), pp.393-397.

Lobo RA, Pickar JH, Wild RA; Walsh B, Hirvonen E (1994): Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group, Obstet Gynecol, (vol. 84), pp.987-995.

Löffler G (1998): Endokrine Funktionen III: Die schnelle Stoffwechselregulation, Löffler G, Petrides PE, Ed, Biochemie und Pathobiochemie, 7. Auflage. ed., pp. 838-864, Springer Verlag, Berlin.

Löffler G (1998): Stoffwechsel von Glucose und Glycogen, Löffler G, Petrides PE, Ed, Biochemie und Pathobiochemie, 7. Auflage. ed., pp. 396-431, Springer Verlag, Berlin.

London SJ, Colditz GA, Stampfer MJ (1989): Prospective study of relative weight, height and risk of breast cancer, J Am Med Assoc, (vol. 65), pp.311-320.

Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R (2002): Birth weight and body weight in young women: a prospective twin study, Am J Clin Nutr, (vol. 75), pp.676-682.

Lorenzini M, Caagliero E, Toledo S, (1985): Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death., Diabetes, (vol. 34), pp.621-627.

Lorini R, Vanelli M (1996): Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. The Prediabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP), J Pediatr Endocrinol Metab, (vol. 9), pp.163-167.

Lovejoy JC (1998): The influence or sex hormones of obesity across the female life span, J Womens Health, (vol. 7), pp.1247-1256.

Lund S, Holman GD, Schmitz O, Pedersen O, (1995): Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin., Proc Natl Acad Sci U.S.A., (vol. 92), pp.5817-5821.

Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenström J (1990): Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes, Diabet Med, (vol. 7), pp.407-413.

Luoto R, Mansito S, Vartiainen E (1998): Hormone replacement therapy and body size: how much does lifestyle explain?, Am J Obstet Gynecol, (vol. 178), pp.66-73.

Luotola H, Pyorala T, Loikkanen M (1986): Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women, Maturitas, (vol. 8), pp.245-253.

Luzi L, DeFronzo RA (1989): Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans, Am J Physiol, (vol. 257), pp.E241-E246.

Lyons TJ (1992): Lipoprotein glycation and its metabolic consequences, Diabetes, (vol. 41), No. Suppl 2, pp.67-73.

Maffeis C, Moghetti P, Gressani A, Clementi M, Gaudino R, Tatò L, (2002): Insulin resistance and the persitance of obesity from childhood into adulthood., J Clin Endocrinol Metab, (vol. 87), pp.71-76.

Magarey AM, Daniels LA, Boulton TJ (2001): Prevalence of overweight and obesity in Australien children and adolescent: reasessment of 1985 and 1995 data against new standard international definition, Med J Aust, (vol. 174), pp.561-564.

Maggio CA, Pi-Sunyer FX (1997): The prevention and treatment of obesity, Diabetes Care, (vol. 20), pp.1744-1766.

Mahmood TA, Templeton A (1991): Peritoneal fluid volume and sex steroids in the preovulatory period in mild endometriosis, Br J Obstet Gynaecol, (vol. 98), pp.179-183.

Mandour T, Kissebah A, Wynn V (1977): Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alterations in the insulin:glucagon molar ratio and the hepatic enzyme activity, Eur J Clin Invest, (vol. 7), pp.181-187.

Manning PJ, Allum A, Jones S, Sutherland WH, Williams SM (2001): The effect or hormone replacement therapy on cardiovascular risk factors in type 2 diabetes. A randomized controlled trial, Arch Intern Med, (vol. 161), pp.1772-1776.

Manson JE, Colditz GA, Stampfer MJ, et al (1990): A prospective study of obesity and risk of coronary heart disease in women, N Engl J Med, (vol. 322), pp.882-889.

Manson JE, Rimm EB, Colditz GA, et al (1992): Parity and incidence of non-insulin-dependent diabetes mellitus, Am J Med, (vol. 93), pp.13-18.

Manson JE, Rimm EB, Colditz GA, et al (1992): A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus, Ann Epidemiol, (vol. 2), pp.665-673.

Manson JE, Rimm EB, Stampfer MJ, et al (1991): Physical activity and incidence of non-insulin-dependent diabetes mellitus in women, Lancet, (vol. 338), pp.774-778.

Manson JE, Willett WC, Stampfer MJ, (1995): Body weight and mortality among women, N Engl J Med, (vol. 333), pp.677-685.

Mantzoros CS, Flier JS, Rogol AD (1997): A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty, J Clin Endocrinol Metab, (vol. 82), pp.1066-1070.

Manwaring P, Morfis L, Diamond T, Howes LG (2000): The effects of hormone replacement therapy on plasma lipids in type 2 diabetes, Maturitas, (vol. 34), pp.239-247.

Marin P, Darin N, Amemiya T, et al (1992): Cortisol secretion in relation to body fat distribution in obese premenopausal women, Metabolism, (vol. 41), pp.882-886.

Markstrom E, Svensson ECh, Shao R, Svanberg B, Billig H, (2002): Survival factors regulating ovarian apoptosis - dependence on follicle differentiation, Reproduction, (vol. 123), pp.23-30.

Maroulis GB (1991): Effect of aging on fertility and pregnancy, Semin Reprod Endocrinol, (vol. 9), pp.165-175.

Marsden PJ, Murdoch A, Taylor R (1996): Adipocyte insulin action during the normal menstrual cycle, Hum Reprod, (vol. 11), pp.968-974.

Martin BC, Warram JH, Krolewski As, Bergmann RN, Soeldner JS, Kahn CR, (1992): Role of glucose and insulin resistance in development of type-2 diabetes mellitus: results of a 25-year follow-up study., Lancet, (vol. 340), pp.925-929.

Mashchak CA, Lobo RA, Dozono-Takano R, et al (1982): Comparison of pharmacodynamic properties of various estrogen formulations, Am J Obstet Gynecol, (vol. 144), pp.511-518.

Mason HD, Margara R, Winston RM, Seppala M, Koistinen R, Franks S (1993): Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in cells from normal and polycystic human ovaries, J Clin Endocrinol Metab, (vol. 76), pp.1275-1279.

Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K (1997): Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans, Nat Med, (vol. 3), pp.1029-1033.

Matkovic V, Iich JZ, Skugor M, Baden hop NE, Goel P, Clairmont A, Klisovic D, Nahhas RW, Landoll JD (1997): Leptin is inversely related to age at menarche in human females, J Clin Endocrinol Metab, (vol. 82), pp.3239-3245.

Matthews K, Meilahn E, Kuller LH, Kelsey S, Caggiula A, Wing R (1989): Menopause and risk factors for coronary heart disease, N Engl J Med, (vol. 321), pp.641-646.

Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD (1987): Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon, J Clin Endocrinol Metab, (vol. 64), pp.596-601. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3493255

McCane DR, Pettitt DJ, Jacobsson LT, Knowler WC, Bennett PH (1994): Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?, BMJ, (vol. 308), pp.942-945.

McDonald GW, Fisher GF, Burnham C (1965): Reproducibility of the oral glucose tolerance test, Diabetes, (vol. 14), pp.473-480.

McDonald I, Crossley JN (1970): Glucose tolerance during the menstrual cycle, Diabetes, (vol. 19), pp.450-452.

McKillop AM, Abdel-Wahab YH, Mooney MH, O´Harte FP, Flatt PR, (2002): Secretino of glycated insulin from pancratic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity., Diabetes Metab, (vol. 28), pp.3S61-3S69.

Meczekalski B, Warenik-Szymankiewicz A (1997): Leptin- missing link between the metabolic state and the reproductive system?, Gynecol Pol, (vol. 68), pp.627-632.

Medici F, Hawa M, Pyke DA, Leslie RD, (1999): Concordance rate for type II diabetes mellitus in monozygotic twins: actuariel analysis., Diabetologia, (vol. 42), pp.146-150.

Meigs JB (2002): Epidemiology of the metabolic syndrome, 2002, Am J Manag Care, (vol. 8), No. Suppl 11, pp.S238-S292.

Meirow D, Yossepowitch O, Rosler A, et al (1995): Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups, Hum Reprod, (vol. 10), pp.1951-1956.

Meisinger C, Thorand B, Schneider A, et al, (2001): Kardiovaskuläre Risikofaktoren und Diabetesinzidenz: Ergebnisse der MONICA- Augsburg- Kohortenstudie 1984 bis1994, Diab Stoffw, (vol. 10), pp.3-11.

Meneilly GS, Dawson K, Tessier D (1993): Alterations in glucose metabolism in the elderly patient with diabetes, Diabetes Care, (vol. 16), pp.1241-1248.

Merimee TJ, Burgess JA, Rabinowitz D (1967): Influence of growth hormone on insulin secretion, Diabetes, (vol. 16), pp.478-482.

Metzger BE, Cho NH, Roston SM, Rodvany R (1993): Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus, Diabetes Care, (vol. 16), pp.1598-1605.

Metzger BE, Coustan DR (Eds) (1998): Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus, Diabetes Care, (vol. 21), No. Suppl 2, pp.B1-B167.

Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D (2000): Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China, Ann Intern Med, (vol. 132), pp.253-260.

Michaelis D, Jutzi E, Albrecht G (1991): Epidemiologie des Diabetes mellitus in der Bevölkerung der ehemaligen DDR: Alters- und geschlechtsspezifische Inzidenz- und Prävalenztrends im Zeitraum 1960-1987, Z Klin Med, (vol. 46), pp.59-64.

Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A (2001): Obstetric outcome in women with polycystic ovarian syndrome, Hum Reprod, (vol. 16), pp.226-229.

Mishell DR Jr. (1997): Evaluation of the infertile couple, Lobo RA, Mishell DR Jr., Paulson RJ, Shoupe D, Ed, Infertility, Contraception, and Reproductive Endocrinology (vol. 4 th ed), pp. 496-506, Balckwell Science, Oxford.

Moberg E, Kollind M, Lins PE, Adamson LU (1995): Day to day variations of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle, Diabetic Med, (vol. 12), pp.224-228.

Modan M, Harris MI, Halkin H (1989): Evalutaion of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples., Diabetes, (vol. 38), pp.1630-1635.

Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo MI (2000): Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation, J Clin Endocrinol Metab, (vol. 85), pp.139-146.

Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo MI, Muggeo M (1996): The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women, J Clin Endocrinol Metab, (vol. 81), pp.952-960.

Mohamed N, Dooley J (1998): Gestational diabetes mellitus and subsequent development of NIDDM in aboriginal women of north-western Ontario, Int J Circumpolar Health, (vol. 57), No. Suppl 1, pp.355-358.

Moore P, Koltermann O, Weyant J, Olefsky JM (1981): Insulin binding in human pregnancy: comparisons to the postpartum, luteal, and follicular states, J Clin Endocrinol Metab, (vol. 52), pp.937-941.

Moorhead T, Hannaford P, Warskyj M (1997): Prevalence and characteristics associated with use of hormone replacement therapy in Britain, Br J Obstet Gynaecol, (vol. 104), pp.290-297.

Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC (1996): Insulin, somatotropic, and luteinizing hormones axes in lean and obese women with polycystic ovary syndrome: common and distinct features, J Clin Endocrinol Metab, (vol. 81), pp.2854-2864.

Moran A, Jacobs D, Steinberger J, Cohen P, Hong C-P, Prineas R, Luepker R, Sinaiko A (1999): Insulin resistance during puberty: results from clamp studies in 357 children, Diabetes, (vol. 48), pp.2039-2044. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10512371

Moran A, Jacobs D, Steinberger J, Cohen P, Hong C-P, Prineas R, Sinaiko A (2002): Association between the insulin resistance of puberty and the insulin-like growth factor-I/ growth hormone axis, J Clin Endocrinol Metab, (vol. 87), pp.4817-4820.

Moran A, Zhang H-J, Olson LK, Harmon JS, Poitout V, Robertson RP, (1997): Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective isulin gene expression in the pancreatic islet cell line, HIT-T15, J Clin Invest, (vol. 99), pp.534-539.

Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikainen HK (1998): Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 83), pp.2566-2568.

Morley JE (1998): Sex hormones and diabetes, Diabetes Rev, (vol. 6), pp.6-15.

Morrison J, Barton B, Biro F, Sprecher D, Falkner F, Obarzanek E (1994): Sexual maturation and obesity in 9- and 10-year-old balck and white girls: the National Heart, Lung, and Blood Institute growth and health study, J Pediatr, (vol. 1246), pp.889-895.

Mosher WD, Pratt WF (1993): The demography of infertility in the United States. 1988 National Center for Health Statistics, Annu Prog Reprod Med, pp.37-43.

Moss SE, Klein R, Klein BEK, Meuer MS, (1984): The association of glycemia and cause-specific mortality in a diabetic population, Arch Int Med, (vol. 154), pp.2473-2479.

Mossberg H-O (1989): 40-year follow-up of overweight children, Lancet, (vol. 26), pp.491-493.

Munoz J, Derstine A, Gower BA (2002): Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement, Obes Res, (vol. 10), pp.424-431.

Must A, Dallal GE, Dietz WH, (1992): Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness., Am J Clin Nutr, (vol. 53), pp.839-846.

Must A, Jaques PF, Dallai GE, Bajema CJ, Dietz WH, (1992): Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935., N Engl J Med, (vol. 327), pp.1350-1355.

Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999): The disease burden associated with overweight and obesity, Jama, (vol. 282), pp.1523-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10546691

Nagamani M, Minh TV, Kelver ME (1986): Hyperinsulinemia in hyperthecosis of the ovaries, Am J Obstet Gynecol, (vol. 154), pp.384-389.

Nagamani M, Stuart CA (1990): Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis., Am J Obstet Gynecol, (vol. 163), pp.1992-1997.

Nagy TR, Gower BA, Towerbridge CA, Dezenberg C, Shewchuk RM, Goran MI, (1997): Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children., J Clin Endocrinol Metab, (vol. 82), pp.2148-2152.

Nahum R, Thong KJ, Hillier SG (1995): Metabolic regulation of androgen production by human thecal cells in vitro, Hum Reprod, (vol. 10), pp.75-81.

Nambi V, Hoogwerf RJ, Sprecher DL (2002): A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia, Cleve Clin J Med, (vol. 69), pp.985-989.

National Heart Lung and Blood Institute (1998): Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report, Obes Res, (vol. 6), No. Suppl 2, pp.51-209.

Nauck MA, Kleine N, Orskov C, Holst JJ, Wilms B, Creutzfeldt W, (1993): Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients., Diabetologia, (vol. 36), pp.741-744.

Naylor CD, Sermer M, Chen E, Sykora K (1996): Cesarean delivery in relation to birthweight and gestational glucose tolerance: pathophysiology or practice style?, JAMA, (vol. 275), pp.1165-1170.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD (2002): Postmenopausal hormone replacement therapy. Scientific review, JAMA, (vol. 288), pp.872-881.

Nestler JE, Barlascini CO, Matt DW, et al (1989): Suppression of serum insulin by diazoxide reduces serum testosterone levels obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 68), pp.1027-1032.

Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998): Effects of metformin of spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome, N Engl J Med, (vol. 338), pp.1876-1880.

Nestler JE, Powers LP, Matt DW, et al (1991): A direct effect of hyperinsulinemia on serum sex hormone binding globulin levels in obese women with the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 72), pp.83-89.

Nestler JE, Singh R, Matt DW, Clore JN, Blackard WG (1990): Suppression of serum insulin level by diozoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women, Am J Obstet Gynecol, (vol. 163), pp.1243-1246.

Nestler JE, Strauss JF (1991): Insulin as an effector of human ovarian and adrenal steroid metabolism., Endocrinol Metab Clin North Am, (vol. 20), pp.807-823.

Nielsen MF, Nyholm B, Caumo A, Chandramouli V, Schumann WC, Cobelli C, Landau BR, Rizza RA, Schmitz O (2000): Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes., Diabetes, (vol. 49), pp.2135-2141.

Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J (1994): Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone, N Engl J Med, (vol. 331), pp.1188-1193.

Norman BH, Shih C, Toth JE, Ray JE, Dodge JA, Johnson DW, Rutherford PG, Schultz RM, Worzalla JF, Vlahos CJ (1996): Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by Wortmannin and related analogs, J Med Chem, (vol. 39), pp.1106-1111.

Norman RJ, Kidson WJ, Cuneo RC, Zacharin MR (2001): Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group, Med J Aust, (vol. 174), pp.580-583.

Notelovitz M, Johnston M, Smith S, Kitchen C (1987): Metabolic and hormonal effects of 25 mg and 50 mg 17 b-estradiol implants in surgically menopausal women, Obstet Gynecol, (vol. 70), pp.749-754.

Nuutila P, Knuuto MJ, Mäki M, Laine H, Ruotsalainen U, Teräs M, Kaaparanta M, Solin O, Yki-Järvinen H (1994): Gender and insulin sensitivity in heart and in skelatal muscle, Diabetes, (vol. 44), pp.31-36.

O´Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC (1994): A prospective study of prevalence of clear-cut endocrine disorders and polycystic ovaries 350 patients presenting with hirsutism or androgenic alopecia, Clin Endocrinol (Oxf), (vol. 41), pp.231-236.

O´Meara N, et al (1993): Defects in b cell function and insulin action functional ovarian hyperandrogenism, J Clin Endocrinol Metab, (vol. 76), pp.1241-1247.

O´Rahilly S, Turner RC, Matthews DR (1988): Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes, N Engl J Med, (vol. 318), pp.1225-1230.

O´Rahilly SP, Nugent Z, Rudenski AS, et al (1986): Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes, Lancet, (vol. ii), pp.360-364.

O´Sullivan J (1991): Diabetes mellitus after GDM, Diabetes, (vol. 29), pp.131-135.

O´Sullivan J, Ho KKY (1995): A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women, J Clin Endocrinol Metab, (vol. 80), pp.1783-1788.

Ogawa Y, Masuzaki K, Hosoda K, Aizawa Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K (1999): Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin, Diabetes, (vol. 48), pp.1822-1829.

Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002): Prevalence and trends in overweight among US children and adolescents, 1999-2000, JAMA, (vol. 288), pp.1728-1732.

Ohlson LO, Larsson B, Björntorp P, et al (1988): Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up participants in a study of Swedish men born in 1913, Diabetologia, (vol. 31), pp.798-805.

Oken E, Gillmann MW (2003): Fetal Origins of obesity, Obes Res, (vol. 11), pp.496-506.

Okosun IS, Liao Y, Rotimi CN, Dever GE, Cooper RS (2000): Impact of birth weight on ethnic variations in subcutaneous and central adiposity in American children aged 5-11 years, Int J Obes Relat Metab Disord, (vol. 24), pp.479-484.

Olefsky JM, Koltermann OG, Scarlett JA, (1982): Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus, Am J Physiol, (vol. 243), pp.E15-E30.

Orban Z, Bornstein SR, Chrousos GP (1998): The interaction between leptin and the hypothalamic-pituitary-thyroid axis, Horm Metab Res, (vol. 30), pp.231-235.

Osei K, Gaillaird TR, Schuster DP (1998): History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes, Diabetes Care, (vol. 21), pp.1250-1257. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9702429

Ovesen P (1998): Synergistic effects of growth hormone and insulin-like growth factor-I on differentiation and replication of cultured human granulosa cells., Acta Obstet Gynecol Scand, (vol. 77), pp.487-91.

Owens D, Collins PB, Johnson A, Tomkin GH (2000): Lipoproteins and low-dose estradiol replacement therapy in post-menopausal type 2 diabetic patients: the effects of addition of norethisterone acetate, Diabetic Med, (vol. 17), pp.308-315.

Owerbach D, Bell GI, Rutter WJ, Shows TB (1980): The insulin gene is located on chromosome 11 in humans., Nature, (vol. 286), pp.82-84.

Pacini G, Valerio A, Beccaro F, Nosadini R, Cobelli C, Crepaldi G (1988): Insulin sensitivity and b-cell responsivity are not decreased in elderly subjects with normal OGTT, J Am Geriatr Soc, (vol. 7), pp.304-307.

Pal BR, Phillips PE, Matthews DR, Dunger DB (1992): Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus, Diabetologia, (vol. 35), pp.542-549. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1612227

Palin SL, Kumar S, Sturdee DW, Barnett AH (2001): HRT women with diabetes- a review of the effect on glucose and lipid metabolism, Diabetes Research and Clinical Practice, (vol. 54), pp.67-77.

Palitzsch K-D, NusserJ, Arndt H, Zietz B, Hügl S, Schäffler A, Büttner R, Frick E, Rath H, Schölmerich J, Diabetomobil-Studiengruppe (1999): Die Prävalenz des Diabetes mellitus wird in Deutschland deutlich unterschätzt- eine bundesweite epidemiologische Studie auf der Basis der HbA1C- Analyse, Diabetes und Stoffwechsel, (vol. 8), pp.189-200.

Pan XR, Li GW, Hu YH, et al (1997): Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study, Diabetes Care, (vol. 20), pp.537-544.

Pasquali R, Antenucci D, Casimirri F, et al (1989): Clinical and hormonal characteristics of obese and amenorrheic hyperandrogenic women before and after weight loss, J Clin Endocrinol Metab, (vol. 68), pp.173-179.

Pasquali R, Casimirri F (1993): The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women, Clin Endocrinol (Oxf), (vol. 39), pp.1-16.

Pasquali R, Fabbri R, Venturoli S, et al (1986): Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries, Am J Obstet Gynecol, (vol. 154), pp.139-144.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM (2000): Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome, J Clin Endocrinol Metab, (vol. 85), pp.2767-2774.

Pasquali R, Venturoli S, Paradisi R, Capelli M, Parenti N, Melchionda N (1982): Insulin and C-peptide levels in obese patients with polycystic ovaries, Horm Metab Res, (vol. 14), pp.284-287.

Patel N, Alsat E, Igout A, Baron F, Hennen G, Porquet D, Evain-Brion D (1995): Glucose inhibits human placental GH secretion, in vitro, J Clin Endocrinol Metab, (vol. 80), pp.1743-1746.

Pedersen O, Hjollund E, Lindskov HO (1982): Insulin binding and action on fat cells from young healthy females and males, Am J Physiol, (vol. 243), pp.E158-E167.

Peiris AN, Mueller RA, Struve MF (1987): Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women, J Clin Endocrinol Metab, (vol. 64), pp.162-169.

Peiris AN, Stagner JL, Plymate SR, Vogel RL, Heck M, Samols E, (1993): Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men., J Clin Endocrinol Metab, (vol. 76), pp.279-282.

Pelleymounter MA, Cullen MJ, Bake MB, et al (1995): Effects of the obese gene product on body weight regulation in ob/ob mice., Science, (vol. 269), pp.540-549.

Peppler U, Thefeld W, Wincenty U (1978): Oraler Glukosetoleranztest bei Frauen in Abhängigkeit vom Menstruationszyklus, Klin Wochenschr, (vol. 56), pp.659-669.

Peraldi P, Xu M, Spiegelmann BM (1997): Thiazolidindiones block tumor necrosis factor-a-induced inhibition if insulin signaling, J Clin Invest, (vol. 100), pp.1863-1869.

Perlman JA, Russel-Briefel R, Ezzati T, Lieberknecht G (1985): Oral glucose tolerance and the potency of contraceptive progestins, J Chronic Dis, (vol. 38), pp.857-864.

Persson I, Adami HO, Bergkvist L, et al (1989): Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with: Results of a prospective study, BMJ, (vol. 298), pp.147-151.

Peserico A, Angeloni G, Bertoli P, Marini A, Piva G, Panciera A, Suma V (1989): Prevalence of polycystic ovaries in women with acne, Arch Dermatol Res, (vol. 281), pp.502-503.

Peters RK, Kjos SL, Xiang A, Buchanan TA (1996): Long-term diabetogenic effect of single pregnancy women with previous gestational diabetes mellitus, Lancet, (vol. 347), pp.227-230.

Petersen KR, Skouby SO, Sidelmann J, Molstedt-Pedersen L, Jespersen J (1994): Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus, Am J Obstet Gynecol, (vol. 171), pp.400-405.

Pettitt DJ (1996): Diabetes in subsequent generations, Dornhorst A, Hadden DR, Ed, Diabetes and pregnancy: an international approach to diagnosis and management, pp. 367-376, John Wiley & Sons Ltd., Chichester.

Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC (1988): Congenital susceptibility to NIDDM. Role of intrauterine environment, Diabetes, (vol. 37), pp.622-628.

Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC (1983): Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy, N Engl J Med, (vol. 308), pp.242-245.

Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR, (1987): Obesity in offspring of diabetic Pima Indian women despite normal birth weight, Diabetes Care, (vol. 10), pp.76-80.

Pietilainen KH, Kaprio J, Rasanen M, Winter T, Rissanen A, Rose R (2001): Tracking of body size from birth to late adolescence: contributions of birth lenght, birth weight, duration of gestation, parent´s body size, and twinship, Am J Epidemiol, (vol. 154), pp.21-29.

Pimenta W, Korytkowski M, Mitrakou A, et al (1995): Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative, JAMA, (vol. 273), pp.1855-1861.

Placek PJ, Taffel SM (1988): Recent patterns in cesarean delivery in the United States, Obstet Gynecol Clin North Am, (vol. 15), pp.607-627.

Plagemann A, Harder T, Kohlhoff R, Rohde W, Dorner G (1997): Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM of gestational diabetes, Diabetologia, (vol. 40), pp.1094-1100.

Plymate SR, Matej LA, Jones RE, Friedl KE (1988): Inhibition of sex hormone-binding globulin production in the human hepatoma (HepG2) cell line by insulin and prolactin., J Clin Endocrinol Metab, (vol. 67), pp.460-464.

Poehlman ET, Toth MJ, Gardner AW (1995): Changes in energy balance and body composition at menopause: A controlled, longitudinal study, Ann Intern Med, (vol. 123), pp.673-675.

Poldermann KH, Gooren LJ, Asscheman H, Bakker A, Heine RJ (1994): Induction of insulin resistance by androgens and estrogens, J Clin Endocrinol Metab, (vol. 79), pp.265-271.

Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E (1988): Quantitative study of insulin secretion and clearance in normal and obese subjects, J Clin Invest, (vol. 81), pp.435-441.

Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR (1994): Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM, Diabetes, (vol. 43), pp.871-877.

Polson DW, Adams J, Wadsworth J, Franks S (1988): Polycystic ovaries - a common finding in normal women, Lancet, (vol. 1), pp.870-872.

Poretsky L, Cataldo NA, Rosenwaks Z, Guidice LC, (1999): The insulin-related ovarian regulatory system in health and disease, Endocr Rev, (vol. 20), pp.535-582.

Poretsky L, Grigorescu F, Seibel M, Moses AC, Flier JS, (1985): Distribution and characterization of the insulin and IGF-1 resceptors in normal human ovary, J Clin Endocrinol Metab, (vol. 61), pp.728-734.

Poretsky L, Kalin M (1987): The gonadotropic function of insulin, Endocr Rev, (vol. 8), pp.132-141.

Poretsky L, Piper B (1994): Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome., Obstet Gynecol, (vol. 84), pp.613-621.

Poretsky L, Smith D, Seibel M, Moses AC, Flier JS, (1984): Specific insulin binding sites in the human ovary., J Clin Endocrinol Metab, (vol. 59), pp.809-811.

Porte D Jr. (1991): Banting Lecture 1990. b-cells in type II diabetes mellitus, Diabetes, (vol. 40), pp.166-180.

Potau N, Ibanez L, Rique S, Carrascosa A (1997): Pubertal changes in insulin secretion and peripheral insulin sensitivity, Horm Res, (vol. 48), pp.219-226.

Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H, (1999): Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study., Diabetologia, (vol. 42), pp.139-145.

Power C, Lake JK, Cole TJ, (1997): Measurements of long-term health risks of child and adolescent fatness., Int J Obes Relat Metab Disord, (vol. 21), pp.507-521.

Pratley RE, Weyer C (2001): The role of impaired early insulin secretion in the pathogenesis of type 2 diabetes mellitus, Diabetologia, (vol. 44), pp.929-945.

Pratley RE, Weyer C, Bogardus C (2000): Metabolic abnormalities in the development of non-insulin-dependent diabetes mellitus, LeRoith D, Taylor SI, Olefsky JM,, Ed, Diabetes Mellitus (vol. 2nd ed), pp. 548-557, Lippincott-Raven, Philadelphia.

Prelevic GM, Wurzburger MI, Balint-Peric L, Hardiman P, Okolo S, Maletic D, Ginsburg J (1992): Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome, Metabolism, (vol. 41), pp.76-79.

Prelevic GM, Wurzburger MI, Balint PL, et al (1992): Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries, Horm Res, (vol. 37), pp.125-131.

Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D (1993): Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study., J Clin Endocrinol Metab, (vol. 76), pp.283-287.

Prigeon RL, Kahn SE, Porte D Jr. (1995): Changes in insulin sensitivity, glucose effectiveness, and ß-cell function in regularly exercising subjects, Metabolism, (vol. 44), pp.1259-1263.

Proudler A, Felton C, Stevenson JC (1992): Aging and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women, Clin Sci, (vol. 83), pp.489-494.

Pyorälä K (1979): Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland, Diab Metab Rev, (vol. 13), pp.345-349.

Radberg T, Gustafson A, Skryten A, Karlsson K (1981): Oral contraception in diabetic women. Diabetes control, serum and high-density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception, Acta Endocrinol, (vol. 98), pp.246-251.

Radon PA, McMahon MJ, Meyer WR (1999): Impaired glucose tolerance in pregnant women with polycystic ovary syndrome, Obstet Gynecol, (vol. 94), pp.194-197.

Randle PJ, Garland P, Hales C, Newholme E (1963): The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, (vol. 1), pp.785-789.

Randle PJ, Priestman DA, Mistry SC, Halsall A (1994): Glucose fatty acid interactions and the regulation of glucose disposal, J Cell Biochem, (vol. 55), No. Suppl, pp.1-11.

Razay G, Heaton KW, Bolton CH (1992): Coronary heart disease risk factors in relation to the menopause, Quart J Med, (vol. 85), pp.889-896.

Reaven G, Miller R (1968): Study of the relationship between glucose and insulin responses to an oral glucose load in man, Diabetes, (vol. 17), pp.560-569.

Reaven GM (1988): Banting lecture: role of insulin resistance in human disease, Diabetes, (vol. 37), pp.1595-1607.

Reaven GM (1994): Syndrome X: 6 years later, J Intern Med, (vol. 236), No. Suppl 736, pp.13-22.

Reaven GM, Hollenbeck CB, Chen YD (1989): Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance, Diabetologia, (vol. 32), pp.52-55.

Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F (1976): Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome, J Clin Invest, (vol. 57), pp.1320-1329.

Rebuffe SM, Martin P, Björntorp P (1991): Effect of testosterone on abdominal adipose tissue in men, Int J Obes, (vol. 15), pp.791-795.

Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH (1997): Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976, BMJ, (vol. 315), pp.396-400.

Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE (1992): Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women, Diabetologia, (vol. 35), pp.967-972.

Risch N (1990): Linkage strategies for genetically complex traits. Multilocus traits, Am J Hum Genet, (vol. 46), pp.222-228.

Rizza RA, Mandarino LJ, Gerich JE (1982): Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization, Diabetes, (vol. 31), pp.663-669. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6761205

Roberts R (1998): Hypertension in women with gestational diabetes, Diabetes Care, (vol. 21), No. Suppl 2, pp.B27-B32.

Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H, (2003): Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection., Diabetes, (vol. 52), pp.581-587.

Robertson RP, Zhang H-J, Pyzdrowski KL, Walseth TF (1992): Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations, J Clin Invest, (vol. 90), pp.320-325.

Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S (1993): The relationship of insulin insensitivity to menstrual pattern win women with hyperandrogenism and polycystic ovary syndrome, Clin Endocrinol (Oxf), (vol. 39), pp.351-355.

Rönnemaa T, Laakso M, Pyorala, Kallio V, Puukka P (1991): High fasting insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects, Arterioscler Thromb, (vol. 11), pp.80-90.

Rosenbloom AL, Wheeler L, Bianchi R, Chin FT, Tiwary CM, Gorgic A (1975): Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents, Diabetes, (vol. 24), pp.820-828. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1158042

Rosenfield RL, Lucky AW (1993): Acne, hirsutism, and alopecia in adolescent girls, Endocrinol Metab Clin North Am, (vol. 22), pp.507-532.

Rossetti L (1995): Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus, Clin Invest Med, (vol. 18), pp.255-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8549010

Roumain J, Brodie TD, Charles MA, Pettitt DJ, De Courten MP, Kowler WC, Hanson RL (1998): The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women, Diabetes Care, (vol. 21), pp.346-349.

Ruderman N, Chrisholm D, Pi-Sunyer X, Schneider S (1998): The metabolically obese, normal-weight individual revisited, Diabetes, (vol. 47), pp.699-713.

Russel-Briefel R, Ezzati TM, Perlman JA, Murphy RS (1987): Impaired glucose tolerance in women using oral contraceptives: United States, 1976-1980, J Chronic Dis, (vol. 40), pp.3-11.

Ryan AS, Nicklas BJ, Berman DM (2002): Hormone replacement therapy, insulin sensitivity, and abdominal obesity postmenopausal women, Diabetes Care, (vol. 25), pp.127-133.

Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J (1995): Defects in insulin secretion and action in women with history of gestational diabetes, Diabetes, (vol. 44), pp.506-512.

Ryan EA, O`Sullivan MJ, Skyler JS (1985): Insulin action during pregnancy: studies with the euglecemic clamp technique, Diabetes, (vol. 34), pp.380-389.

Saad MF, Damani S, Gingerich RL, Raid-Gabriel MG, Khan A, Boyadijan R, et al (1997): Sexual dimorphism in plasma leptin concentration, J Clin Endocrinol Metab, (vol. 82), pp.579-584.

Saenger P (2000): Metabolic consequences of growth treatment in paediatric practice, Horm Res, (vol. 53), No. Suppl 1, pp.60-69.

Sagawa N, Yura S; Itoh, H.; Mise, H.; Kakui, K.; Korita, D.; Takemura, M.; Nuamah, M. A.; Ogawa, Y.; Masuzaki, H.; Nakao, K. and Fujii, S. (2002): Role of leptin in pregnancy. A review, Placenta, (vol. 23), No. Suppl A, pp.S80-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11978063

Sagle M, Bishop K, Ridles N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S (1988): Recurrent early miscarriage and polycystic ovaries, Br Med J, (vol. 297), pp.1027-1028.

Sakul J, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C (1997): Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians, Am J Hum Genet, (vol. 60), pp.651-656.

Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV (1999): Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes, Diabetes Care, (vol. 22), pp.1401-1407.

Samoto T, Maruo T, Matsuo H, Katayama K, Barnea ER, Mochizuki M, (1993): Altered expression of insulin and insulin-like growth factor-I receptors in follicular and stromal compartements of polycystic ovaries., Endocr J, (vol. 40), pp.413-424.

Sampson M, Kong C, Patel A, Unwin R, Jacobs HS (1996): Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome, Clin Endocrinol (Oxf), (vol. 45), pp.623-629.

Savage MO, Smith CP, Dunger DB, Gale EA, Holly JM, Preece MA (1992): Insulin and growth factors adaptation to normal puberty, Horm Res, (vol. 37), No. Suppl 3, pp.70-73.

Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL (2002): Clinical predictors for a high risk for the development of diabetes mellitus in early puerperium in women with recent gestational diabetes mellitus, Am J Obstet Gynecol, (vol. 186), pp.751-756.

Schaefer-Graf UM, Buchanan TA, Xiang AH, Songster G, Montoro M, Kjos SL (2000): Patterns of congenital anomalies and relationship to initial maternal fasting glucose in pregnancies complicated by type 2 and gestational diabetes, Am J Obstet Gynecol, (vol. 182), pp.313-320.

Scheen AJ, Paquot N, Letiexhe MR, Paolisso G, Castillo MJ, Lefebvre PJ (1995): Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies, Int J Obes Relat Metab Disord, (vol. 19), No. Suppl 3, pp.S14-20.

Scherbaum WA (2001): Kohlenhydratstoffwechsel, Siegenthaler W, Ed, Klinische Pathophysiologie, 8.. ed., pp. 61-103, Thieme, New York.

Schreibman PH (1968): Alterations in carbohydrate and lipid metabolism by a progestin, Diabetes, (vol. 17), No. Suppl 1, pp.341-342.

Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J , Hanitsch S Attanasio A, Blum WF (1997): Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight, J Clin Endocrinol Metab, (vol. 82), pp.1480-1483.

Schwartz NS, Clutter WE, Shah SD, et al (1987): Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold symptoms, J Clin Invest, (vol. 79), pp.777-781.

Schwartz S, Raskin P, Fonseca V, Graveline JF (1998): Effect of troglitazone in insulin-treated patients with type II diabetes mellitus, N Engl J Med, (vol. 338), pp.861-866.

Seidell JC (2000): Obesity, insulin resistance and diabetes- a worldwide epidemic, Br J Nutr, (vol. 83), No. Suppl 1, pp.S5-8.

Seino S, Seino M, Bell GI (1990): Human insulin-receptor gene, Diabetes, (vol. 39), pp.129-133.

Selby PL, Oakley CE (1992): Women´s problems and diabetes, Diabetic Med, (vol. 9), pp.290-292.

Sellers TA, Kushi LH, Potter JD, et al (1992): Effect of family history, body fat distribution and reproductive factors on the risk of postmenopausal breast cancer, N Engl J Med, (vol. 326), pp.1323-1329.

Seminara S, Merello G, Masi S, Filpo A, La Cauza F, D´Onghia G, Martelli E, Loche S (1998): Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency, Clin Endocrinol (Oxf), (vol. 49), pp.125-130.

Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T (1993): Do obese children become obese adults? a review of the literature, Prev Med, (vol. 22), pp.167-177.

Sermer M, Naylor CD, Farine D, et al (1998): The Toronto Tri-Hospital Gestational Project: a preliminary review, Diabetes Care, (vol. 21), No. Suppl 2, pp.B33-B42.

Sesti G (2002): Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes?, Ann Med, (vol. 34), pp.444-450.

Shamma FN, Rossi G, HajHassan L, Penzias AS, Connoly-Diamond M, Jones E, Diamond MP (1995): The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions, Fertil Steril, (vol. 63), pp.767-772.

Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, et al (1999): Impaired fasting glucose of impaired glucose tolerance. What best predicts future diabetes in Mauritius?, Diabetes Care, (vol. 22), pp.399-402.

Sherif K (1999): Benefits and risks of oral contraceptives, Am J Obstet Gynecol, (vol. 180), No. Suppl, pp.S343-S348.

Shoupe D, Kumar DD, Lobo RA (1983): Insulin resistance in polycystic ovary syndrome, Am J Obstet Gynecol, (vol. 147), pp.588-592.

Shoupe D, Lobo RA (1984): The influence of androgens on insulin resistance, Fertil Steril, (vol. 41), p.385.

Sigal RJ, Warram JH (1996): The interaction between obesity and diabetes, Curr Opin Endocrinol Diab, (vol. 3), pp.3-9.

Silverman BL, Metzger BE, Cho NH, Loeb CA (1995): Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism, Diabetes Care, (vol. 18), pp.611-617.

Silverman BL, Rizzo T, Green OC, et al (1991): Long-term prospective evaluation of offspring of diabetic mothers, Diabetes, (vol. 40), No. Suppl 2, pp.121-125.

Simon D, Senan C, Garnier P, Saint-Paul M, Garat E, Thibult N, Papoz L (1990): Effects of oral contraceptives on carbohydrate and lipid metabolism in a healthy population: the Telecom study, Am J Obstet Gynecol, (vol. 163), pp.382-387.

Simone DA, Mahesh VB (1993): An autoregulatory process for androgen production in rat thecal-interstitial cells, Biol Reprod, (vol. 48), pp.46-56.

Singh A, Hamilton-Fairley D, Koistinen R, Seppala M, James VH, Franks S, Reed MJ (1990): Effect of insulin-like growth factor-I (IGF-I) and insulin on the secretion of sex hormone-binding globulin and IGF-binding protein (IGFBP-1) by human hepatoma cells, J Endocrinol, (vol. 124), pp.R1-3.

Singh K, Viegas OA, Loke DF, Ratnam SS (1992): Effekt of Norplant implants on liver, lipid and carbohydrate metabolism, Contraception, (vol. 45), pp.141-153.

Singh R, Nagpaul JP, Chakravarti RN, Dhall GI (1985): Effect of short-term and long-term treatment with a steroidal oral contraceptive on the intestinal absorption of nutrients in vitro in female rats, Digestion, (vol. 32), pp.63-69.

Sinha R, Fisch G, Teague B, et al (2002): Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl J Med, (vol. 346), pp.802-810.

Sivitz WI, Walsh SA, Morgan DA, Thomas ML, Haynes WG (1997): Effect of Leptin on insulin sensitivity in normal rats, Endocrinology, (vol. 138), pp.3395-3401.

Skarfors ET, Selinus KI, Lithell HO (1991): Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala, BMJ, (vol. 303), pp.755-760.

Skouby SO, Anderson O, Kühl C (1986): Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes, Am J Obstet Gynecol, (vol. 155), pp.802-807.

Skouby SO, Anderson O, Saurbrey N, Kühl C (1987): Oral contraception and insulin sensitivity: in vivo assessment normal women and women with previous gestational diabetes, J Clin Endocrinol Metab, (vol. 64), pp.519-523.

Skouby SO, Molstedt-Petersen L, Kühl C, Bennet P (1986): Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles, Fertil Steril, (vol. 46), pp.858-864.

Smith CP, Archibald HR, Thomas JM, Tarn AC, Williams AJ, Gale EA, Savage MO (1988): Basal and stimulated insulin levels rise with advancing puberty, Clin Endocrinol (Oxf), (vol. 28), pp.7-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3048793

Smith CP, Dunger DB, Williams AJ, Taylor AM, Perry LA, Gale EA, Preece MA, Savage MO (1989): Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life, J Clin Endocrinol Metab, (vol. 68), pp.932-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2523898

Smith JT, Waddell BJ (2003): Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids, Endocrinology, (vol. 144), pp.3024-3030.

Smith S, Ravnikar VA, Barbieri RL (1987): Androgen and insulin response to oral glucose challenge in hyperandrogenic women, Fertil Steril, (vol. 48), pp.72-77.

Soler JT, Folsom AR, Kaye SA, Prineas RJ (1989): Association of abdominal obesity, fasting insulin, sex hormone binding globulin and estrone with lipids and lipoproteins in postmenopausal women, Atherosclerosis, (vol. 79), pp.21-27.

Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE (2001): Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus, JAMA, (vol. 286), pp.2421-2426.

Soman V, DeFronzo R (1980): Direct evidence for downregulation of insulin receptors by physiologic hyperinsulinaemia in man, Diabetes, (vol. 29), pp.159-163.

Spellacy WN (1982): Carbohydrate metabolism during treatment with estrogen, and low-dose oral contraceptives, Am J Obstet Gynecol, (vol. 142), pp.732-734.

Spellacy WN, Buhi W, Birk S (1972): The effect of the progestogen ethynodiol diacetate on glucose. Insulin and growth hormone levels after 6 months´ treatment, Acta Endocrinol, (vol. 70), pp.373-384.

Spellacy WN, Buhi W, Birk S (1972): The effects of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ehtinyl estradiol for six months, Am J Obstet Gynecol, (vol. 114), pp.378-390.

Spellacy WN, Buhi W, Birk S (1975): Effect of northindrone on carbohydrate and lipid metabolism, Obstet Gynecol, (vol. 46), pp.560-563.

Spellacy WN, Buhi W, Birk S (1978): Effect of estrogen treatment for one year on carbohydrate and lipid metabolism in women with normal and abnormal glucose tolerance test results, Am J Obstet Gynecol, (vol. 131), pp.87-90.

Spellacy WN, Buhi W, Birk SA, Cabal R (1973): The effects of estrogens, progestogen, oral contraceptives and intrauterine devices on fasting triglyceride and insulin levels, Fertil Steril, (vol. 24), pp.178-184.

Spellacy WN, Buhi W, Spellacy CE, Moses LE, Goldzieher JW (1970): Glucose, insulin and growth hormone studies in long-term users of oral contraceptives, Am J Obstet Gynecol, (vol. 106), pp.173-182.

Spellacy WN, Carlson KL, Schade SL (1967): Menstrual cycle carbohydrate metabolism, Am J Obstet Gynecol, (vol. 99), pp.382-386.

Spellacy WN, McLeod AG, Buhi WC, Birk SA (1972): The effects of medroxyprogesterone acetate on carbohydrate metabolism: measurements of glucose, insulin, and growth hormone after twelve months´ use, Fertil Steril, (vol. 23), pp.239-244.

Spellacy WN, Newton R, Buhi W, Birk S (1973): Carbohydrate and lipid studies during six months´ treatment with megestrol acetate, Am J Obstet Gynecol, (vol. 116), pp.1074-1078.

Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead M, Stevenson JC (2000): Effects of oral and transdermal 17 b-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women, Metabolism, (vol. 49), pp.742-747.

Speroff L, Darney PD (1996): Oral contraception: a clinical guide for contraception, 2nd ed. ed., William & Wilkins, Baltimore.

Spira A (1988): The decline of fecundity with age, Maturitas, No. Suppl 1, pp.15-22.

Spitzer WO (1998): Bias versus causality: Interpreting recent evidence of oral contraceptive studies, Am J Obstet Gynecol, (vol. 179), pp.S43-S50.

Srinivasan SR, Myers L, Berenson GS (2002): Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood, Diabetes, (vol. 51), pp.204-209.

Srivastava M, Oakley N, Tompkins C, Sonksen P, Wynn V (1975): Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids, Eur J Clin Invest, (vol. 5), pp.425-433.

Staffieri JR (1967): A study of social stereotype of body image in children, J Perspect Soc Psychol, (vol. 7), pp.101-104.

Stamler J (1991): Epidemiologic findings on body mass and blood pressure in adults., Ann Epidemiol, (vol. 1), pp.347-362.

Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1985): A prospective study of postmenopausal estrogen therapy on coronary heart disease, N Engl J Med, (vol. 313), pp.1044-1049.

Starke AAR (2000): Pathogenese und Pathophysiologie der Makroangiopathie des Diabetes mellitus, Berger M, Ed, Diabetes mellitus (vol. 2. Auflage), pp. 445-454, Urban & Fischer, München. Jena.

Steel JM, Irvine WJ, Clarke BF (1980): The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy, J Clin Lab Immunol, (vol. 4), pp.83-85.

Stein IF, Leventhal ML (1935): Amenorrhea associated with bilateral polycystic ovaries, Am J Obstet Gynecol, (vol. 29), pp.181-191.

Steinberger J, Moorehead C, Katch V, Rocchini AP (1995): Relationship between insulin resistance and abnormal lipid profile in obese adolescents, J Pediatr, (vol. 126), pp.690-695. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7751990

Steiner G (1997): Diabetes and atherosclerosis - a lipoprotein perspective, Diabetic Medicine, (vol. 14), pp.S38-S44.

Steinhart JR, Sugarman JR, Connell FA (1997): Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM, Diabetes Care, (vol. 20), pp.943-947.

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001): The hormone resistin links obesity to diabetes, Nature, (vol. 409), pp.307-312.

Stern MP (1991): Kelly West Lecture: primary prevention of type 2 diabetes mellitus, Diabetes Care, (vol. 14), pp.399-410.

Stevenson JC (1996): Metabolic effects of the menopause and oestrogen replacement, Baillère's Clin Obstet Gynaecol, (vol. 10), pp.449-467.

Strauss RS, Pollack HA (2001): Epidemic increase in childhood overweight in 1986-1998, JAMA, (vol. 286), pp.2845-2848.

Straznicky NE, Barrington VE, Branley P, Louis WJ (1998): A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women, J Hypertens, (vol. 16), pp.357-368.

Striker GE (2001): Editorial: Glucose toxicity, Kidn Int, (vol. 59), pp.799-800.

Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M (1998): Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus, Clin Pediatr (Phila), (vol. 37), pp.73-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9492114

Stumvoll M, Häring H (2001): Insulin resistance and insulin sensitizers, Horm Res, (vol. 55), No. Suppl 2, pp.3-13.

Sun SS, Schubert CM, Chumlea WC, Roche AF, Kulin HE, Lee PA, Himes JH, Ryan AS (2002): National estimates or the timing of sexual maturation and racial differences among US children, Pediatrics, (vol. 110), pp.911-919.

Surrey ES, Halme J (1990): Effects of peritoneal fluid from endometriosis patients on endometrial stromal cells in vitro, Obstet Gynecol, (vol. 76), pp.792-799.

Svec F, Natasi K, Hilton C, Srinivasan SR, Berenson GS (1992): Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study, Diabetes, (vol. 41), pp.313-317.

Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagata I, Florant GL, Tokuyama K, (1994): Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis, Metab Clin Exp, (vol. 43), pp.714-718.

Tankeyoon M, Dusitsin N, Poshyachinda V, Larsson-Cohn U (1976): A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive, Contraception, (vol. 14), pp.199-214.

Taubert H-D, Kuhl H (1995): Kontrazeption mit Hormonen. Ein Leitfaden dür die Praxis, 2. ed. ed., Georg Thieme Verlag, Stuttgart - New York.

Tchernof A, Poehlmann ET (1998): Effects of the menopause transition on body fatness and body fat distribution, Obes Res, (vol. 6), pp.246-54.

The DECODE Study Group (1999): Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria, Lancet, (vol. 354), pp.617-621.

The ESHRE Capri Workshop (1996): Infertility revisited: the state of the art today and tomorrow, Hum Reprod, (vol. 11), pp.1779-1807.

The ESHRE Capri Workshop (1997): Female infertility: treatment option for complicated cases, Hum Reprod, (vol. 12), pp.1191-1196.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003): Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, (vol. 26), No. Suppl 1, pp.S5-S20.

The North American Menopause Society (2000): Consensus Opinion: Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: Consensus opinion of the North American Menopause Society, Menopause, (vol. 7), pp.87-95.

The Writing group for the 3rd European Conference on Sex Steroids and Cardiovascular Diseases (2003): The European Consensus Development Conference 2002: Sex steroids and cardiovascular diseases on the route to combined evidence from OC and HRT/ERT, Maturitas, (vol. 44), pp.69-82.

The Writing group for the PEPI Trial (1995): Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Intervention (PEPI) Trial, JAMA, (vol. 273), pp.199-108.

Thom M, Chakravarti S, Oram DH, Studd JW (1977): Effects of hormone replacement therapy on glucose tolerance in postmenopausal women, Br J Obstet Gynaecol, (vol. 84), pp.776-783.

Thorburn AW, Proietto J (1999): Peripheral tissue glucose uptake is not reduced after an oral glucose tolerance load in Southern Italian subjects at risk for developing non-insulin-dependent diabetes mellitus, Metabolism, (vol. 48), pp.80-85.

Törnberg SA, Carstensen JM (1994): Relationship between Quetelet index and cancer of breast and female genital tract in 47 000 women followed 25 years., Br J Cancer, (vol. 69), pp.358-361.

Toth E, Suthijumroon A, Crockford P, Ryan E (1987): Insulin action does not change during the menstrual cycle in normal women, J Clin Endocrinol Metab, (vol. 64), pp.74-80.

Toth MJ, Sites CK, Eltabbakh GH, Poehlmann ET (2000): Effects on menopausal status on insulin-stimulated glucose disposal. Comparison of middle-aged premenopausal and early postmenopausal women, Diabetes Care, (vol. 23), pp.801-806.

Toublanc JE (1997): Modifications of growth hormone secretion during female puberty, Ann N Y Acad Sci, (vol. 816), pp.60-75.

Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH (1995): Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children, J Clin Endocrinol Metab, (vol. 80), pp.172-178.

Travers SH, Jeffers BW, Eckel RH (2002): Insulin resistance during puberty and future fat accumulation, J Clin Endocrinol Metab, (vol. 87), pp.3814-3818. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12161515

Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH (1998): Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children, J Clin Endocrinol Metab, (vol. 83), pp.1935-1939.

Trimble ER, Atkinson AB, Buchanan KD, Hadden DR (1980): Plasma glucagon and insulin concentrations in acromegaly, J Clin Endocrinol Metab, (vol. 51), p.626.

Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen M-R, Tuomi T, Groop LC (2000): Insulin secretion and insulin sensitivity in relation to glucose tolerance. Lessons from the Botnia Study, Diabetes, (vol. 49), pp.975-980.

Troisi RJ, Cowie CC, Harris MI (2000): Hormone replacement therapy and glucose metabolism, Obstet Gynecol, (vol. 96), pp.665-670.

Troisi RJ, Cowie CC, Harris MI (2000): Oral contraceptive use and glucose metabolism in a national sample of women in the United States, Am J Obstet Gynecol, (vol. 183), pp.389-395.

Tsibris J, Raynor L, Buhi W, Buggie J, Spellacy W (1980): Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term, J Clin Endocrinol Metab, (vol. 51), pp.711-717.

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kuikaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001): Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, (vol. 344), pp.1343-1350.

Tuomilehto J, Wolf E (1987): Primary prevention of diabetes mellitus, Diabetes Care, (vol. 10), pp.238-248.

Turhan NÖ, Seckin NC, Aybar F, Inegöl I (2003): Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients, Int J Gynecol Obstet, (vol. 81), pp.163-168.

Tuttle S, Turkington VE (1974): Effects of medroxyprogesterone acetate on carbohydrate metabolism, Obstet Gynecol, (vol. 43), pp.685-692.

Umpierrez GE, Casals MMC, Gebhardt SSP, Mizon PS, Clark WS, Phillips LS, (1995): Diabetic ketoacidosis in obese African-American., Diabetes, (vol. 44), pp.79-85.

Urbanek M, Legro RS, Driscoll D, Strauss JF, Dunaif A, Spielman RS (2000): Searching for the polycystic ovary syndrome genes, J Pediatr Endocrinol Metab, (vol. 13), No. Suppl 5, pp.1311-1313.

Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G (1999): Risk of diabetes in the new diagnostic category of impaired glucose: a prospective analysis, Diabetes Care, (vol. 22), pp.1490-1493.

Valdes CT, Elkind-Hirsch KE (1991): Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle, J Clin Endocrinol Metab, (vol. 72), pp.642-646.

Van der Spuy ZM, Steer PJ, McCusker M, Steele MJ, Jacobs HS (1988): Outcome of pregnancy in underweight women after spontaneous and induced ovulation, Br Med J, (vol. 296), pp.962-965.

Vanhala M, Vanhala P, Kumpusalo E, et al (1998): Relationship between obesity from childhood to adulthood and the metabolic syndrome: population based study, BMJ, (vol. 317), p.319.

Velazquez EM, Mendoza S, Hamer T, et al (1994): Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy, Metabolism, (vol. 43), pp.647-654.

Vermeulen A, Daneels R, Thiery M (1970): Effects of oral contraceptives on carbohydrate metabolism, Diabetologia, (vol. 6), pp.519-523.

Vermeulen A, Thiery M (1974): Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives, Diabetologia, (vol. 10), pp.253-259.

Wabitsch M, Jensen PB, Blum WF, et al (1996): Insulin and cortisol promote leptin production in cultured human fat cells, Diabetes, (vol. 45), pp.1435-1438.

Waine H, Frieden EH, Caplan HI, et al (1963): Metabolic effects of Enovid in rheumatoid patients, Arthritis Rheum, (vol. 6), p.796.

Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF Jr (1988): Hyperfunction of the hypothalamic-pituary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization, J Clin Endocrinol Metab, (vol. 66), pp.165-172.

Wallace RB, Heiss G, Burrows B, et al (1987): Contrasting diet and body mass among users and non-users of oral contraceptives and exogenous estrogens: The Lipid Research Clinics Program Prevalence Study, Am J Epidemiol, (vol. 125), pp.854-859.

Walsh CH, Malins JM (1977): Menstruation and control of diabetes, Br J Med, (vol. 11), p.177.

Walton C, Godsland IF, Prouldler AJ, Felton CV, Wynn V (1992): Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men, J Clin Endocrinol Metab, (vol. 75), pp.170-175.

Walton C, Godsland IF, Prouldler AJ, Wynn V, Stevenson JC (1993): The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women, Eur J Clin Invest, (vol. 23), pp.466-473.

Wang JT, Ho LT, Tang KT, Wang LM, Chen Y-D, Reaven GM (1989): Effect of habitual physical activity on age-related glucose intolerance, J Am Geriatr Soc, (vol. 37), pp.203-209.

Wang Y (2002): Is obesity associated with early sexual maturation? A comparison of the association in American Boys versus girls, Pediatrics, (vol. 110), pp.903-910.

Ward WK, Johnston CL, Beard JC, Benedetti TJ, Halter JB, Porte D Jr (1985): Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus, Diabetes, (vol. 34), pp.861-869.

Warne DK, Charles MA, Hanson RL, Jacobsson LTH, McCane DR, Knowler WC, Pettitt DJ (1995): Comparison of body size measurements as predictors of NIDDM in Pima Indians, Diabetes Care, (vol. 4), pp.435-439.

Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990): Slow glucose removal rate and hyperinsuliemia precede the development of type II diabetes in the offspring of diabetic parents, Ann Intern Med, (vol. 113), pp.909-915.

Watanabe RN, Azen CG, Roy S, Perlman JA, Bergman RN (1994): Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors, J Clin Endocrinol Metab, (vol. 79), pp.1277-1283.

Wauters M, Considine RV, Yudkin JS, Peiffer F, De Leeuw I, Van Gaal LF (2003): Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion, Horm Metab Res, (vol. 35), pp.92-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12734788

Wauters M, Mertens I, Rankinen I, Chagnon M, Bouchard C, Gall Van (2001): Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance, J Clin Endocrinol Metab, (vol. 86), pp.3227-3232.

Weigle DS (1997): Leptin and other secretory products of adipocytes modulate multiple physiological functions, Ann Endocrinol (Paris), (vol. 58), pp.132-136.

Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Milson E (1974): Blood pressure in women taking oral contraceptives, BMJ, (vol. 1), pp.533-535.

Weiss DJ, Charles MA, Dunaif A, Prior DE, Lillioja S, Knowler WC, Herman WH (1994): Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women, Metabolism, (vol. 43), pp.803-807.

Welborn TA, Stenhouse NS, Johnstone CG (1969): Factors determing serum-insulin response in a population sample, Diabetologia, (vol. 5), pp.263-266.

Welborn TA, Wearne K (1979): Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations, Diabetes Care, (vol. 2), pp.154-160.

Westwood M, Gibson JM, Pennells LA, White A (1999): Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle, Am J Obstet Gynecol, (vol. 180), pp.530-536.

Weyer C, Bogardus C, Mott DM, Pratley RE (1999): The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus, J Clin Invest, (vol. 104), pp.787-794.

Weyer C, Bogardus C, Pratley RE (1999): Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance, Diabetes, (vol. 48), pp.2197-2203. http://diabetes.diabetesjournals.org/cgi/content/abstract/48/11/2197

Weyer C, Bogardus C, Tataranni PA, Pratley RE (2001): Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development, Diabetes Care, (vol. 24), pp.89-94.

Widom B, Diamond MP, Simonson DC (1992): Alterations in glucose metabolism during menstrual cycle in women with IDDM, Diabetes Care, (vol. 15), pp.213-220.

Wiesenthal SR, Sandhu H, McCall RH, et al (1999): Free fatty acids impair hepatic insulin extraction in vivo, Diabetes, (vol. 48), pp.766-774.

Wilcox JG, Hwang JG, Hodis HN, Sevanian A, Stanczyk FZ, Lobo RA (1997): Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein, Fertil Steril, (vol. 67), pp.57-62.

Wild RA (1995): Obesity, lipids, cardiovascular risk, and androgen excess, Am J Med, (vol. 98), No. Suppl 1A, pp.27S-32S.

Wilden PA, Siddle K, Haring E, Backer JM, White MF, Kahn CR (1992): The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities, J Biol Chem, (vol. 267), pp.13719-13727.

Wilhelmsen L, Rosengren A, Eriksson H, Lappas G (2001): Heart failure in the general population of men - morbidity, risk factors, and prognosis, J Intern Med, (vol. 249), pp.253-261.

Williams DP, Going SB, Lohmann TG, Harsha DW, Srinivasan SR, Webber LS, et al (1992): Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents., AM J Public Health, (vol. 82), pp.358-363.

Willis D, Franks S (1995): Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin resceptor and not the type-I insulin-like growth factor receptor., J Clin Endocrinol Metab, (vol. 80), pp.3788-3790.

Willis D, Mason H, Gilling-Smith C, Franks S, (1996): Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries, J Clin Endocrinol Metab, (vol. 81), pp.302-309.

Wilson CA, Weyer C, Knowler WC, Pratley RE (1999): Acute insulin secretion is impaired in adult offspring of diabetic pregnancies, Diabetes, (vol. 48), No. Suppl 1, p.A300.

Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PM (1991): Weight gain at the time of menopause, Arch Intern Med, (vol. 151), pp.97-102.

Wingard DL, Barrett-Connor EL, Ferrara A (1995): Is insulin really a heart disease risk factor, Diabetes Care, (vol. 18), pp.1299-1304.

Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner Weir S, White MF, (1998): Disruption of IRS-2 causes type 2 diabetes in mice., Nature, (vol. 391), pp.900-904.

Wittemann JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA (1989): Increased risk of atherosclerosis in women after the menopause, BMJ, (vol. 298), pp.642-644.

Wolfe HM, Gross TL (1994): Obesity in pregnancy, Clin Obstet Gynecol, (vol. 37), pp.596-604.

Woodward TS, Burghen GZ, Kitabachi AE, Wiliams JA (1981): Glucose intolerance and insulin resistance in aplastic anaemia treated with oxymetholone, J Clin Endocrinol Metab, (vol. 53), pp.905-908.

World Health Organization (WHO) 1998Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June 1997GenevaWHO

Wortsman J, de Angeles S, Futterweit W, et al (1991): Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome, J Reprod Med, (vol. 36), pp.659-661.

Writing group for the Women´s Health Initiative Investigators (2002): Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women´s Health Initiative randomized controlled trial, JAMA, (vol. 288), pp.321-333.

Wynn V (1982): Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism, Am J Obstet Gynecol, (vol. 142), pp.739-764.

Wynn V, Doar J (1966): Some effects of oral contraceptives on carbohydrate metabolism, Lancet, (vol. ii), pp.715-719.

Wynn V, Doar J (1969): Some effects of oral contraceptives on carbohydrate metabolism, Lancet, (vol. ii), pp.761-766.

Wynn V, Godsland I, Niththyananthan R, Adams PW, Melrose J, Oakley NW, Seed M (1979): Comparison of effects of different combined oral contraceptive formulations on carbohydrate and lipid metabolism, Lancet, (vol. 1), pp.1045-1049.

Wynn V, Mills GL, Doar JW, Stokes T (1969): Fasting serum triglycerides, cholesterol, and lipoprotein levels during oral contraceptive therapy, Lancet, (vol. 2), pp.756-760.

Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999): Multiple metabolic defects during late pregnancy in women with high risk for type 2 diabetes mellitus, Diabetes, (vol. 48), pp.848-854.

Yalow RS, Berson SA (1960): Plasma insulin concentrations in nondiabetics and early diabetic subjects, Diabetes, (vol. 9), p.254.

Yamashita H, Shao J, Ishizuka T, Klepcyk PJ, Muhlenkamp P, Quiao L, Hoggard N, Friedman JE (2001): Leptin administration prevents spontaneous gestational diabetes in heterozygous Leprdb/+ mice: Effects on placental leptin and fetal growth, Endocrinology, (vol. 142), pp.2888-2897.

Yen SSC (1980): The polycystic ovary syndrome, Clin Endocrinol (Oxf), (vol. 12), pp.177-208.

Yki-Järvinen H (1984): Insulin sensitivity during the menstrual cycle, J Clin Endocrinol Metab, (vol. 59), pp.350-353.

Yki-Järvinen H (1984): Sex and insulin sensitivity., Metab Clin Exp, (vol. 33), pp.1011-1015.

Yki-Järvinen H (1992): Glucose toxicity, Endocr Rev, (vol. ), pp.415-431.

Yki-Järvinen H, Koivisto VA (1983): Effects of body composition on insulin sensitivity, Diabetes, (vol. 32), pp.965-969.

Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A,Uchigata Y, Omori Y (1997): Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications, Diabetes Care, (vol. 20), pp.844-847. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9135953

Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, Takemura M, Fuji S (2003): Resistin is expressed in the human placenta, J Clin Endocrinol Metab, (vol. 88), pp.1394-1397.

Yura S, Sagawa N, Ogawa Y, Masuzaki H, Itoh H, Ebihara K, Aizawa-Abe M, Fuji S, Nakao K (1998): Augmentation of leptin synthesis and secretion through activation of protein kinases A and C in cultured human trophoblastic cells, J Clin Endocrinol Metab, (vol. 83), pp.3609-3614.

Zaadstra BM, Seidell JC, Van Noord PA, et al (1993): Fat and female fecundity: prospective study of the effect of body fat distribution on conception rates, Br Med J, (vol. 306), pp.484-487.

Zachow RJ, Magoffin DA (1997): Direct intraovarian effects of leptin - impairement of insulin-like growth factor-1 on follicle stimulating hormone-dependent estradiol-17-beta production by rat ovarian granulosa cells, Endocrinol, (vol. 138), pp.847-850.

Zadik Z, Chalew SA, McCarter RJ Jr., Meistas M, Kowarski AA (1985): The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals, J Clin Endocrinol Metab, (vol. 60), pp.513-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3972964

Zamboni M, Armellini F, Harris T, et al (1997): Effects of age on body fat distribution and cardiovascular risk factors in women, Am J Clin Nutr, (vol. 66), pp.111-115.

Zawadzki JK, Dunaif A (1992): Diagnostic criteria for polycystic ovary syndrome: towards a rational approach., Dunaif A, Givens JR, Haseltine FP, Merriam GR, Ed, Polycystic ovary syndrome, pp. 377-384, Blackwell Scientific, Cambridge, MA.

Zhang L, Rodriquez H, Ohno S, Miller WL (1995): Serine phosphorylation of human P450c17 increases 17,20 lyase activity: implications for adrenarche and the polycystic ovary syndrome, Proc Natl Acad Sci USA, (vol. 92), pp.10619-10623.

Zhang Y, Proenca R, Maffel M, Barone M , Leopold L, Friedmann JM, (1994): Position cloning of the mouse obese gene and its human homologue., Nature, (vol. 372), pp.425-432.

Zhang YW, Stern B, Rebar RW (1984): Endocrine comparison of obese menstruating and amenorrheic women, J Clin Endocrinol Metab, (vol. 58), pp.1077-1083.

Zhou J, Bondy C (1993): Anatomy of the human ovarian insulin-like growth factor system., Biol Reprod, (vol. 48), pp.467-482.

Zimmet PZ (1988): Primary prevention of diabetes mellitus in women, Diabetes Care, (vol. 11), pp.258-262.

Zimmet PZ (1992): Kelly West Lecture 1991: challenges in diabetes epidemiology from west to the rest., Diabetes Care, (vol. 15), pp.232-252.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
18.01.2008